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ABSTRACT 
TITLE: 
A study to assess the effectiveness of soya milk with honey on reducing symptoms on 
postmenopausal women in selected area of Chennai. 
About 80% of women between the age group of 45-55 yrs develop few 
or more menopausal symptoms that begin from months and proceeds to years 
after menopause.  
Need for the study:  
      More than 60% of postmenopausal women in Choolai have been suffering 
from menopausal symptoms which affect their daily activities. There is a need 
of natural approaches to relieve menopausal discomfort and soya is considered 
as asuper natural food which contains Isoflavones ( genistein, daidzein, and 
glycitein ) are bioactive compounds with mildly estrogenic properties and often 
referred to as phyto estrogen  that  relieve the menopausal symptoms. 
Objectives: 
           The aim of this study is to assess the pre and post test level of 
menopausal symptoms among the post menopausal women and to evaluate the 
effectiveness of soya milk in reducing those symptoms thereby associating with 
the selected demographic variables. 
(Keywords: soya milk, menopausal symptoms, isoflavones, bio active 
compounds, phyto estrogens). 
Methodology:A experimental study was conducted to find out the 
effectiveness of soya milk in reducing the postmenopausal symptoms among 
the women with in the age group of 40-60 years.60 postmenopausal women 
with symptoms were identified in selected areas of Choolai.  
  
Research approach: quantitative approach. 
Research design:  Experimental  pre test post test control groupdesign.  
Sampling technique:  Simple random sampling by lottery method  
Sample size: 60 post menopausal women ,30 in control and 30 in experimental 
group with symptoms. 
Study population: post menopausal women within 40-60 age group in selected 
areas of Choolai. 
Data collection procedure: About 100 ml of soya milk was administered once 
a day in the mid morning for Two weeks. At the end of the fourth week 
symptoms were assessed in both experimental and control group using 
Menopausal Rating Scale. 
Data analysis: Data analyzed through descriptive (frequency, percentage, 
distribution, mean, standard deviation) for demographic variable and inferential 
statistical (independent and paired µW¶WHVW chi square test)  for clinical variables. 
Study results: The mean before administration of soya milk was 17.17 and 
after administration were 10.27. The overall pretest and post test difference in 
control group is 3.9% and in experimental group it is 23.0%,  
Discussion: This shows the effectiveness of soya milk on post menopausal 
symptoms. (p<=0.001).There is significant difference in mean pre menopausal 
symptoms and mean post menopausal symptoms,thus the hypothesis was 
proved 
Conclusion: 
The study was concluded with the findings that there is a significant 
improvement in women under the experimental group who consumed soya 
PLONZLWKDµW¶YDOXHp=0.001) respectively. 
  
                                       CHAPTER I 
                                     INTRODUCTION 
³.QRZOHGJH&RPHV)URP([SHULHQFH,QIRUPDWLRQ,V1RW.QRZOHGJHDQG
WKH2QO\6RXUFHRI.QRZOHGJH,V([SHULHQFH´ 
                                                            ------ ALBERT EINSTEIN 
 
            Aging is the natural progression of changes in structure and function 
that occur with the passage of time in the absence of known disease. Aging of 
the female reproductive system begins at 20 weeks gestation with regard to 
follicle atresia and proceeds as a continuum. 
Menarche is the beginning of the menstrual function, puberty 
culminates in the onset of menstruation, the first period being called 
menarche(Myles). The timing of menarche is influenced by female biology, 
as well as genetic and environmental factors, especially nutritional factors. 
Menopause means permanent cessation of menstruation at the end of 
reproductive life due to loss of ovarian follicular activity. It is the point of time 
when last and final menstruation occurs (Myles). Menopause is defined by the 
world health organization and the stages of reproductive aging workshop 
ZRUNLQJ JURXS ³DV WKH SHUPDQHQW FHVVDWLRQ RIPHQVWUXDO SHULRGV WKDW RFFXUV
QDWXUDOO\RULVLQGXFHGE\VXUJHU\FKHPRWKHUDS\RUUDGLDWLRQ´ 
The age of menopause ranges between 45-55 yrs average being 50 yrs. The 
ZRUG ³PHQRSDXVH´ OLWHUDOO\ PHDQV WKH ³HQG RI PRQWKO\ F\FOHV´ WKH HQG of  
monthly periods or menstruation) when the endocrine and other changes begin, 
and to the 5-15 yrs after the menopause when menopausal symptoms are most 
acute. 
  
              According to, National institute of aging 2012 Many women go 
through the menopausal transition with few or no symptoms, wholesome have 
VLJQLILFDQW RU GLVDEOLQJ V\PSWRPV )RU PRVW ZRPHQ WKHUH¶V QR FDXVH IRU
alarm or medical intervention.  80 percent of women said they were irritable, 
fatigued, and had feelings of despair during the menopausal phase of their 
lives. 
            About 40 billion people in India and m0re than 60% in Chennai were 
affected by menopausal symptoms. The stages of the menopause have been 
classified in to pre menopause, peri menopause, menopause and post 
PHQRSDXVH7KHWHUP´SRVWPHQRSDXVH´  applies to the whole of the women 
life after the menopause, extending in to old age when the pathological changes 
due to loss of ovarian function may become manifested. Menopausal symptoms 
are treated by hormonal and non hormonal therapies. The   most commonly 
used hormonal therapies are progesterone, estrogen, combined progesterone 
therapy. The non hormonal treatments include nutritional diet like soya beans, 
green leafs and supplementary calcium and vitamins (D.c.Dutta, 2009)  
                    The global scenario is now changing towards the use of non toxic 
plant products    having traditional medicinal use. For the last few years there 
has been an increasing trend and awareness in to use supplementation foods.  
          Soya is a naturally, easily available anywhere and it is found to be safe to 
use. Isoflavone is important active compound of soya it has medicinal 
properties that will treat the menopausal symptoms. Soya milk is a supplement 
to the menopausal women. There are many different isoflavones found in 
plants. The isoflavones with the most estrogen like actions are daidzein, 
genistein formononetin and biochanin. They are found in differing amounts in 
various legumes. Soya milk contains Isoflavones (genistein, daidzein, and 
glycitein ) are bioactive compounds with mildly estrogenic properties and often 
referred to as phyto estrogen  that  relieve the menopausal symptoms. 
  
                     The dietary supplements like soya beans, helps in reducing 
menopausal symptoms like hot flushes, insomnia etc...                      
5HVHDUFKHUVVDLGµ(DWLQJVR\DIRRGVRUXVLQJVXSSOHPHQWVGHULYHGIURPZKROH
soya beans, may work better for women.  
1.1 Need for the study: 
Awareness is infinite treasure.....trace it, try it, trust it 
                                 As our population ages, the number of postmenopausal 
women grows. It is estimated that in 1998, there were over 477 million 
postmenopausal women in the world. That number is projected to rise  to 1.1 
billion by the year 2025. 60% of women in Chennai were affected by these 
menopausal symptoms that affect daily quality of life. 
In the developed world, mean life expectancy for women since 1990 has 
increased from 50 to 81 years.. Today, there are over 200 million 
postmenopausal women worldwide and 40 million in India. According to the 
World Health Organization they estimated that by 2025 there will be 1.1 billion 
women above the age of 50 years experiencing menopause and the average age 
of experiencing the symptoms of menopause is 47.5years.  
             National family health survey - 2 (NFHS) analyzed the issue of 
menopause as an emerging issue in India in 2005. They assessed the variation 
in the level of menopause in India and its states. The variation with respect to 
different socioeconomic, demographic nutritional and reproductive related 
variables implied that the large number of women from poor socioeconomic 
status reached menopause early compared with their counterparts. As India is 
still characterized by a large number of illiterate women getting married at an 
early age with poor nutritional levels, the problems of early menopause may 
continue to be a burden in the future too. 
The most common symptoms are: Hot Flushes, Night Sweats, Irregular 
Periods, Loss of Libido, and Vaginal Dryness, Anxieties, difficulty in 
  
concentrating, overreacting to minor upsets, quickly being irritated, 
forgetfulness and mood swings, insomnia or disturbed sleep may also be 
experienced. There is evidence that estrogen loss plays a role. 
Hormone replacement therapy is being considered as the treatment 
approach to relieve menopausal problems, becoming the most common risk 
factor for some of the disease like breast cancer, uterine cancer, ovarian cancer, 
colorectal cancer, venous thrombosis, DQG GHPHQWLD LQFOXGLQJ $O]KHLPHU¶V
disease. There was a positive correlation between knowledge of menopause 
and its remedial measures. soyabean is commonly called wonder bean since it 
is an excellent source of nutrients such as fats , proteins, carbohydrates, 
vitamins and minerals. It contains 19.5gms of fat, 21 gm of carbohydrates and 
provides 432 kcal per 100gm soyabean also contains a family of hemial 
compounds called phyto estrogens..Eating 100 gm of soya protein per day 
provides 200mg of soya isoflavones. A target range of 80-160 mg of 
isoflavones per day is needed for adequate relief of menopausal symptoms.  
Lakshmi Narayanabairy, Shaliny Adega,(2009) conducted a study 
that in the Indian menopause society research there are about 65 million Indian 
women over the age of 45 and estimated that in the year 2026 , the population 
in India will be approximately 1.4 billion, people over 60 years will be 173 
million and the menopausal population will be 103 million. The average age of 
Indian menopausal women with symptom is 47.5 years. There is a need of 
natural approaches to relieve menopausal discomfort and soya is considered as 
³VXSHUIRRG´IRUUHOLHYLQJPHQRSDXVDOV\PSWRPV 
       Though researchers focus on menopausal symptoms they always forget 
that there is a need to concentrate on post menopausal women (one year after 
menopause )who also have symptoms but  are omitted.  The community health 
nurse should play major role to create awareness about menopause and various 
cost effective remedies to reduce the menopausal symptoms during her home 
visits. 
  
1.2  Statement of the problem: 
 ³$VWXG\ WRDVVHVV WKH HIIHFWLYHQHVVRI VR\DPLONZLWKKRQH\FRQVXPSWLRQ
on reducing physical and physiologial symptoms  among the post 
menopausal women with in age group 40-60yrs at Choolai, FKHQQDL´ 
1.3 Objectives of the study: 
` To assess the pre test level of menopausal symptoms among postmenopausal 
women in experimental group and control group. 
` To assess the post test level of menopausal symptoms among postmenopausal 
women in control group and experimental group. 
` To evaluate the effectiveness of soya milk on menopausal symptoms among 
postmenopausal women in experimental group. 
` To associate the menopausal symptoms among post menopausal women and 
their selected demographic variables. 
 
1.4 Operational Definition: 
Assess: 
 It refers to measuring the level of menopausal symptoms among post 
menopausal women. 
Effctiveness 
Statistical significant difference in menopausal symptoms before and after 
administration of soya milk among post menopausal women assessed by 
menopausal rating scale. 
 
  
Soya Milk 
             It refers to milk extracted from soya which is a natural food containing 
phytoestrogens which replace isoflavones that acts as estrogens in the body. 
supplementation of 100 ml  prepared milk of soya   (containing is flavones 120 
mg energy 34.4kcal, total fat 3.2 g including omega 3-.11g, omega 6-.56g 
fiber1g, protein 3.2g)  
Soya Milk with Honey: 
                5ml of   Honey is added with soyamilk to enhance taste and flavor.  
Honey is good for health that helps to prevent pre hypertensive factors like 
palpitation, anxiety etc. 
Post Menopausal Women 
    Refers to women aged about 40-60 years with transition time after 
menopausa whch has gone through 12 consecutive months without a 
menstrual period. 
Physical and pysological  Symptoms 
It refers to, Physical symptoms like sweating, insomnia physiological 
symptoms like cardiac complaints, urinary complaints, joints and muscle 
complaints, experienced by post menopausal women which is measured 
through menopausal rating scale. 
1.5 Assumptions: 
The researcher assumes that 
¾ Menopausal symptoms differ from each woman as it is normal sequence of 
ageing process. 
¾ Consumption of soyamilk reduces the menopausal symptoms among the post 
menopausal women. 
  
¾ Reduction of menopausal symptoms may improve the quality of life of post 
menopausal women. 
1.6 Hypotheses 
H1: 
There is a significant effect in the reduction of level of physicsl and 
physiological symptoms among the post menopausal women after soya milk 
with honey consumption . 
H2:  
There is a significant association between the reduction level of 
menopausal symptoms among postmenopausal women and their selected 
demographic variables. 
1.7 Delimitations 
The study was 
  Delimited to only post menopausal women with symptoms 
 Conducted only for a period of four weeks. 
 The study was delimited with in Choolai premises only. 
 
 
 
 
 
 
  
 
CHAPTER II 
2.1 REVIEW LITERATURE 
 
               The task of reviewing literature involves the identification, location, 
selection, analysis and written description of information on the topic of 
interest. This chapter deals with a review of published and unpublished 
Research studies and from related material for the present study. This helps the 
Investigator in building the basement of the study. 
 
The review of literature for the study is presented under the following heading, 
2.1 Literature related to prevalence of menopausal symptoms 
2.2 Literature related to health benefits of soya bean consumption  
2.3 Literature related to effectiveness of soya milk upon menopausal symptoms 
 
2.1 Literature related to prevalence of menopausal symptoms 
Cheng, Peng-Fei et al ,(2015) conducted a descriptive study to measure 
the association between selected factors and menopausal problems among 90 
working women aged between 45-56 at Erode district. A self administered 
questionnaire was used to collect the data and data were analyzed by using 
descriptive and inferential statistics. The problems assessed were vasomotor 
changes, physiological body changes and sexual changes. The major findings 
suggested were there was a significant relationship between level of 
  
menopausal problems and age of the women Ȥ  3 DQG WKH
duration of menopause. s 
Nitin joseph et al. (2014) conducted a cross sectional study; the Mean 
age of the participants were 54.2 ± 7.2 years. Most of the participants were 
postmenopausal women 80 (72.7%) followed by perimenopausal 17 (15.5%) 
and premenopausal women 13 (11.8%). There was no significant correlation 
between the number of menopausal symptoms with age (r = 0.05, P = 0.623), 
However a significant association was found between the number of 
menopausal symptoms and educational status of participants with the mean 
number of symptoms increasing with increasing educational status (F = 
2.218, P = 0.047). 
Akanksha Singhet al. (2013) conducted a cross-sectional study to 
assess Menopausal symptoms of postmenopausal women in a rural community 
of Delhi, India. In this study by using self-designed, semi structured, interview 
based, oral questionnaire to determine the mean age at attaining menopause and 
the prevalence of various self-reported menopausal symptoms complained by 
252 postmenopausal women (40-54 years).  The result of the study was, the 
mean age at attaining menopause was 46.24 (postmenopausal women 
experienced at least one or more menopausal symptom(s).It was concluded that 
it is necessary to critically introspect health needs of postmenopausal women 
and specific components can be incorporated in the national health programs. 
Mathews (2013) conducted descriptive study to assess of post 
menopausal symptoms among women attending various outreach clinics in 
South Canara District of India. This study was hence done to assess the pattern 
and severity of menopausal symptoms and to find out the factors associated 
with these symptoms for ZRPHQ¶VLQWKHDJHJURXSRI-65 years selected by 
convenient sampling method. Data regarding menopausal symptom was 
obtained by interviewing each participant using the menopause rating scale 
questionnaire. The result of the study was: Mean ages of the participants were 
  
54.2 ± 7.2 years and mean age of attainment of menopause was 48.4 ± 4.5 
years.. Commonest symptom reported was joint and muscular discomfort and 
physical and mental exhaustion seen in 94 (85.4%) participants. It was 
concluded that more of menopausal clinics are needed for awareness 
generation, early recognition and treatment of related morbidities. 
Rahman et al. (2010) conducted a descriptive study to assess the 
menopausal symptoms using modified menopause rating scale (MRS) among 
middle age women in sarawale. In this study by using modified MRS 
questionnaire, 356 The result of study was the mean age of menopause was 
51.3 years (range 47-56 years). The most prevalent symptoms reported were 
joint and muscular discomfort (80.1%), physical and mental exhaustion 
(67.1%) and sleeping problems (52.2%). Followed by symptoms of hot flushes 
and sweating (41.6%), irritability (37.9%), dryness of vagina (37.6%), anxiety 
(36.58%), and depressive mood (32.6%).. It was concluded that the prevalence 
of menopausal symptoms using modified MRS in this study correspond to 
other studies on Asian women. 
Mariane et al. (2010) conducted study on quality life of menopausal 
women Sixty-two women aged 44-55 referring to and academic outpatient 
clinic in Shiraz were selected by simple random sampling, and allocated in two 
groups. Data was collected using a modified Hildich questionnaire on quality-
of-life in menopause stage. Quality-of-life of the subjects (vasomotor, 
psychosocial, physical and sexual aspects) were evaluated prior to and 3 
months after educational intervention. Results:. The study group showed a 
significant improvement in their quality-of-life (p= 0.001). 
Keenan et al. (2010) conducted a cross sectional phone survey to assess 
severity of menopausal symptoms and use of both conventional and 
complementary therapies. In this study 2,602 women aged 45 years or older 
were selected, the participants were asked a series of questions about their 
menopausal states, menopausal symptoms, healthcare provider selection and 
  
therapies used for menopausal symptoms, the highest prevalence estimates 
were reported for hot flashes (62.9%), night sweats (48.3%) and trouble 
sleeping (41.1%). The researcher concluded that. 46% of women used 
complementary / alternative therapies either alone or in combination with 
conventional therapies, whereas a one third of the women did not use any 
therapy in relation to menopause. 
Liee Kar (2009) conducted the prevalence of menopausal symptoms the 
mean age of menopause was 51.3 years (range 47 - 56years). The most 
prevalent symptoms reported were joint and muscular discomfort (80.1%); 
physical and mental exhaustion (67.1%); and sleeping problems (52.2%) 
Followed by symptoms of hot flushes and sweating (41.6%); irritability 
(37.9%); dryness of vagina (37.9%); anxiety (36.5%); depressive mood 
(32.6%). Other complaints noted were sexual problems (30.9%); bladder 
problem (13.8%) and heart discomfort (18.3%). postmenopausal (n=133) 
women. However uro genital symptoms mostly occur in the postmenopausal 
group of women. 
Gharaibeh et al. (2009) conducted descriptive study to assess the severity 
of menopausal symptoms of Jordanian women. Cross-sectional design was 
used. Data were collected from 350 Jordanian women using a self administered 
questionnaire consisting of socio demographic, medical and obstetrical history 
and the Greene climacteric scale. The result 0f the study on the severity of 
menopausal symptoms showed that 15.7%, 66.9% and 17.4% were 
experiencing severe, moderate and mild menopausal symptoms, respectively. 
Vasomotor signs were reported to have the highest scores of severity as 
manifested by hot flushes and night sweating.  
Peeyananjarassri K et al. (2009) conducted a cross-sectional study to 
evaluate menopausal symptoms and quality of life in middle-aged women. The 
data collected from 270 women aged between 45-65 years who attended the 
menopause and gynecological clinic, by using the Menopause quality of life 
  
questionnaire as the tool. The results stated that the mean age at menopause of 
the postmenopausal women was 48.7 years. The prevalence of the menopausal 
symptoms like night sweats, hot flashes and vaginal dryness among the women 
aged 45-65 years were 20.8%, 36.8% and 55.3% respectively. The researcher 
concluded that perimenopausal and postmenopausal women had a significant 
decrease in quality of life compared to premenopausal women. 
ManinderKaur and InduTalwar (2009) Anthropologist, the study was 
attempting to estimate age at natural menopause among rural and urban Punjabi 
Brahmin females of Roop Nagar district (Punjab). Cross-sectional data are 
based on 870 Brahmin females (rural=450, urban=420), ranging in age from 40 
to 70 years. Mean and median age at menopause of rural females is 48.22+2.47 
years and 48.98+1.12 years respectively, while among urban females it is 
49.30+2.80 years and 50.12+1.15 years. The researcher concluded that females 
between the age group 40-55 must be concentrated as they experience more 
symptoms. 
Nisar et al. (2008) conducted study at outpatient department of Isra 
University, Total 863 women of age 42 to 80 years were interviewed in 
outpatient department. A semi structured questionnaire was used to collect 
data. (78.79%) women considered menopause as a natural process, these 
women were of age 45 to 58 years and (59.4%) were uneducated. Frequently 
reported symptoms were Backache in (75.66%), body aches, 576(66.74%) and 
Insomnia in (63.44%) women. Vasomotor symptoms were reported by (59.4%) 
and 390 (45.19%) respectively. 318 (36.84%) women were bothered by 
menopausal symptoms but only (31.86%) has consulted doctor. 649 (75.20%) 
women were not taking any medicine for symptoms, 08 (0.926%) were taking 
Herbs, 10 (1.15%) were on HRT. 
Aaron And Mulliyil (2002) conducted a cross sectional studies on 
medico social dimensions of menopausal women in India 100 menopausal and 
100 premenopausal women were selected. The study findings showed 69% of 
  
the women in menopause complained of diminishing abilities, 23% felt sexual 
life ends with the onset of menopause, 63% reported that their husband had 
become disinterested in them after menopause and 11% were apprehensive of 
loss of feminity. 
Kronenberg (200) performed A recent review of a number of studies 
using alternative methods for menopause symptoms. Twelve studies using soy 
RU VR\ H[WUDFWV ZHUH HYDOXDWHG 6R\ DSSHDUHG WR KDYH D µPRGHVW¶ EHQHILW LQ
reducing hot flashes. Soy based foods seemed to be more effective than 
traditional isoflavone supplement preparations.  The authors comment that 
µIRRGV WKDW FRQWDLQ SK\WRHVWURJHQV VKRZ SURPLVH IRU WKH WUHDWPHQW RI
PHQRSDXVHV\PSWRPV¶ 
 
2.2 Literature related to health benefits of soya bean consumption: 
Aedin Cassidy et al. (2013) conducted a controlled double-blind 
randomised controlled trials (RCT on healthy post-menopausal women. For 
emerging areas all available human studies in post-menopausal women were 
reviewed. In order to make cross comparisons between studies the doses of 
isoflavones were calculated as aglycone equivalents. There is a suggestion, 
but no conclusive evidence, that isoflavones from the sources studied so far 
have a beneficial effect on bone health. The consumption of whole-soyabean 
foods and soyabean-protein isolates has some beneficial effects on lipid 
markers of cardiovascular risk. 
Khalid Zaheer (2013) conducted a descriptive study to review current 
research on the effects of soy consumption on menopausal symptoms. 
Isoflavones were hailed as magical natural component that attribute to 
prevent some major prevailing health concerns, Consumption of soy 
products have been linked to reduction in incidence or severity of chronic 
diseases such as cardiovascular, breast and prostate cancers, menopausal 
  
symptoms, bone loss etc. Overall, consuming moderate amounts of 
traditionally prepared and minimally processed soy foods may offer 
modest health benefits while minimizing potential for any adverse health 
effects. 
Katoh R et al. (2010) conducted a meta-analysis of randomized controlled 
trials study to evaluate the effectiveness of Soy isoflavone intake increases 
bone mineral density in the spine of menopausal women. Ten studies with a 
total of 608 subjects were selected for meta-analysis. The spine bone mineral 
density in subjects who consumed isoflavones increased significantly by 20.6 
mg/cm (2) in comparison to that in subjects who did not consume isoflavones.. 
Increases in the spine bone mineral density with isoflavone intake of more than 
90 mg/day and with treatment lasting 6 months were 28.5mg/cm(2) and 27 
mg/cm(2) respectively. It is concluded that soy isoflavone consumption for 6 
months can be enough to exert beneficial effects on bone in menopausal 
women. 
Carmignani, LO et al. (2009) a randomized controlled trial study to 
assess the effect of dietary soy supplementation compared to estrogen and 
placebo on menopausal symptoms. Sixty healthy, symptomatic, 
postmenopausal women of 40-60 years of age were allocated to use dietary soy 
supplementation (containing 90 mg of isoflavone). Main outcome measures: 
the Menopause Rating Scale (MRS) was used to assess menopausal symptoms 
at baseline and after 16 weeks of treatment. Comparison between groups 
revealed a statistically significant improvement in somatic symptoms (hot 
flashes and muscle pain) in the users of HT (-45.6%) and dietary soy 
supplementation (-49.8%). Urogenital symptoms (vaginal dryness) improved 
significantly in HT users (-38.6%) and in users of the dietary soy 
supplementation (-31.2%).A study concluded that Dietary soy supplementation 
may constitute an effective alternative therapy for somatic and urogenital 
symptoms of the menopause. 
  
Kavitha (2010) conducted a  experimental study  in Chennai and  found 
that the mean, standard deviation of menopausal symptoms in control group 
were same before and after administration of soya (M=30.96, SD=7.950),were 
as in experimental 
 group the mean and standard deviation were (M=9.93, SD=6.99) in 
comparison with before administration of soya (M=31.5, SD=8.12) The 
difference was found statistically significant at P<0.001 level of confidence and 
it can be attributed to the effectiveness of administration of soya. 
 
Aparna (2010) conducted a survey to review current research on the effects 
of soy consumption on menopausal symptoms. The methods used were meta- 
analysis and individual clinical trials. The survey reported that isoflavone 
supplementation was associated with a 34% reduction in hot flashes, with 
increased efficacy as the baseline number of flashes .This study concluded that 
consumption of 30 mg/day of soy isoflavones (or at least 15 mg genistein) 
reduces hot flashes by up to 50 %. The greatest benefit may be realized when 
the isoflavone-rich food or supplement taken in divided doses by subjects who 
experience at least four, hot flashes/day. 
SyedaBatoolMazhar and SabeenaRasheed (2008) the study was 
conducted to determine the value of Menopause Rating Scale (MRS) in 
assessing Postmenopausal women. Fifty women fulfilling the study criteria 
were interviewed. The most commonly reported symptoms were hot flushes 
(90%) and sleep disturbances (89%) followed by palpitations (42%). Sexual 
problems (18%) and bladder symptoms (12%) were reported least frequently. It 
was concluded that Menopause rating scale was easily and rapidly administered 
comprehensive tool for assessing symptoms of climacteric women.  
Kuzer (2008) conducted the study to review current research on the effects 
of soy consumption on menopausal symptoms. Researcher concluded that 
  
consumption of 30mg/day of soy isoflavones reduced hot flashes by up to 50%. 
7KLV WRWDO UHGXFWLRQ LQFOXGHV WKDW SURYLGHG E\ ³WKH SODFHER HIIHFW´ ,W ZDV
concluded that the greatest benefit may be realized when the isoflavone rich 
food or supplement is taken, the subjects experience reduced symptoms of at 
least four hot flashes /day. (, p=0.001) 
Kyung k.soares, Mm.j.Haider (2002) conducted a randomized double 
blinded study in Brazil was conducted among 80 women between 45-55 years, 
to assess the effectiveness of soy isoflavone. The subjects were subject to the 
therapy and re-examined for 4 months. The statistical analysis showed that a 
decrease n menopausal symptoms after 4 months <p=0.01 between the base 
line and the isoflavone group p<0.01 between placebo and isoflavone and 
group. This study also showed that there was a decrease in low density 
lipoproteins which suggest a positive effect on cardiac diseases.  
 Ferrari A (2008). conducted a study to investigate the efficacy of soy 
isoflavone on climacteric symptoms in postmenopausal women. In this study, a 
total of 80 women with mean age 55.1 years, who reported 5 or more hot flush 
episodes per day, were randomized to receive either 250 mg of standardized 
soy extract (Glycine max AT) a total of 100mg/day of isoflavone. For 10-
months, climacteric symptoms were evaluated using a score card and the 
menopausal Kupperman index. After 10 months, there was a significant 
reduction in frequency of hot flushes among isoflavone users when compared 
to those on placebo (p<0.001).Soy isoflavone was significantly superior to 
placebo, in reducing hot flush severity (69.9%, (p<0.001). The study concluded 
that the soy isoflavone extract exerted favorable effects on vasomotor 
symptoms and good compliance, providing a safe and effective alternative 
therapeutic for postmenopausal women. 
Coplin.S (2000) states that soya bean is commonly called wonder bean 
since excellent source of nutrients such as proteins, fats, carbohydrates, 
vitamins, and minerals. It contains 43 grams of protein per 100 grams which is 
  
highest among pulses. It contains 19.5 grams of fat, 21 grams of carbohydrate 
and 432 k.cal per 100 gm. 100gms of soya gives 200 mg of isoflavones that 
helps in reducing post menopausal symptoms. 
 
2.3 Literature Related To Effectiveness of Soya Milk 
Mansoreh Nourozi, et al. (2015) performed as a randomized clinical 
trial among 264 postmenopausal women aged between 45 and 60 in the Vali-e-
asr Reproductive Research Center, the Endocrine and Metabolism Research 
Center and the Women Research Center at Alzahra University,The probability 
of this risk in women with severe hot flashes is 3.58 against women with low to 
moderate hot flashes. Therefore, effective and safe treatment that reduces the 
symptoms can improve the quality of life 
Maya.c.koshy (2012) conducted a study to assess the effectiveness of 
soya bean on menopausal symptoms among 60 post PHQRSDXVHZRPHQ¶V LQ
Salem district. Samples were selected by purposive sampling and data was 
collected using modified Greene climacteric scale. The mean post test 
menopausal problem 4.37 was less than the mean pre test 24.93.the obtained 
³W´ YDOXH  S ZDV KLJKO\ VLJQLILFDQW ,W LV FRQFOXGHG WKDW
significant reduction in the mean menopausal problem after soya bean 
administration. 
Hachul et al. (2011) conducted a study to assess the effectiveness of 
soybean on reducing post menopause insomnia. Two groups of postmenopausal 
women with insomnia participated in the study: the first received 80 mg 
isoflavones daily for 4 months, Thirty-eight women were enrolled in the study. 
Polysomnography revealed a significant increase in sleep efficiency in the 
isoflavone group (from 77.9% to 83.9%) when compared with the placebo 
group (from 77.6% to 81.2%). Is flavones induced a decrease in the intensity 
and number of hot flashes and the frequency of insomnia: The studies 
  
concluded that isoflavone treatment was effective (<p=0.03) in reducing 
insomnia symptoms, which was confirmed by increased sleep efficiency as 
observed by polysomnographic analysis. 
Manubakiam (2010) an experimental study was conducted to assess the 
effectiveness of soya bean upon menopausal symptoms among 60 menopausal 
women in the age group of 45 ± 56years. Soya bean was administered 50 g 
once daily for 30 days. That revealed that post test mean 11.5 was lesser than 
SUH WHVW PHDQ  LQ H[SHULPHQWDO JURXS 7KH REWDLQHGµW¶ YDOXH  ZDV
highly significant at 0.05 level. Soya bean consumption was effective 
(<p=0.01) on menopausal symptoms among women between 45-56 years. 
Hence it was concluded that soya consumption was effective. 
Charlotte Atkinson et al. (2010) conducted a double-blind, 
randomized, placebo-controlled trial to determine the effects of phytoestrogen 
LVRIODYRQHVRQERQHGHQVLW\LQZRPHQZRPHQ¶V-65 yrs) were enrolled 
in this study. Red clover-derived isoflavone supplement that provided a daily 
dose of 26 mg biochanin A, 16 mg formononetin, 1 mg genistein, and 0.5 mg 
daidzein for 1 year bone formation markers were significantly increased in the 
intervention group compared with placebo in postmenopausal women.  It was 
concluded that isoflavones have a potentially protective effect on the lumbar 
spine in women. 
              P jagadeesh Rao (2010) conducted a scientific study w to investigate 
the influence of soya isoflavones on menopausal symptoms among 
postmenopausal women. One hundred and four postmenopausal women 
examined the consumption of 60 grams of isolated soy protein with 60 grams 
of the common milk protein (casein) per day for 8 weeks. Women recorded the 
severity of hot flash daily in menopause dairy. After fourth week of treatment, 
identified as the soy bean, which can reduce the frequency and intensity of hot 
flushes by 45% among postmenopausal women, which was significantly 
different from the milk protein group. The study finding revealed that 
  
phytoestrogens for their role in diminishing menopausal symptoms related to 
estrogen deficiency. 
Cheng G et.al. (2010) conducted the double-blind prospective study by 
Nutrition institute Sweden to evaluate the effects of isoflavone treatment in 
postmenopausal women. Sixty healthy postmenopausal women were randomly 
assigned by computer into two groups to receive 60 mg isoflavones or placebo 
daily for 3 months. Before and after treatment, climacteric symptoms were 
recorded; In women receiving 60 mg isoflavones daily, hot flashes and night 
sweats were reduced by 57% and 43%,(p=0.001) respectively. The study 
concluded that short-term prospective study implies that isoflavones could be 
used to relieve acute menopausal symptoms. 
K. Geeta et al. (2010) this was a purposive randomized intervention 
trial which assessed the occurrence of postmenopausal symptoms problems and 
effectiveness of soy protein isolate and calcium supplementation on 
overcoming these symptoms in 100 postmenopausal subjects. Somatic 
complaints were reported by 49.43% to 70.78% of the women and were 
significantly (p<0.05) more prevalent than psychological complaints (17.97% 
to 98.87%) and uro genital problems. Majority of the subjects (83.14%) had 
moderate degree of problems. Soy protein isolate intervention was effective in 
reducing most of the somatic problems in 8.00% to 58.82% of the subjects. 
Maximum improvement was reported on flushes, heart problems and sleep 
disturbances.. Thus, dietary interventions in the form of soy protein isolate and 
calcium help in decreasing postmenopausal problems. 
Anne Lethaby et al. (2013)conducted the double blind, randomized 
place to controlled study to find effectiveness of soy in receiving vasomotor 
symptom in postmenopausal women. This study carried out with 177 post-
menopausal women, with mean age of 55 years. The test was double blind and 
before the test the postmenopausal women daily five or more not flushes, the 
most important menopausal symptom. After 2 weeks a decreases in the group 
  
(40%) who took isoflavones was noticed. It was concluded that soy isoflavones 
was effective (p=0.03) in reducing frequency and severity of flushes but did not 
stimulate the endometrium in menopausal women. 
Petri Nahas E et al. (2010) conducted a prospective, double-blind and 
placebo-controlled study to evaluate the effects of isoflavones on vasomotor 
symptoms 50 postmenopausal women randomly divided into two groups: 25 
women on soy germ isoflavones (60 mg per day, capsules) and 25 women on 
placebo. The isoflavone group showed increased estradiol levels with 
unchanged FSH, LH, and vaginal cytology, and a reduction of 11.8% in LDL 
and an increase of 27.3% in HDL .It was concluded that Soy gram isoflavone 
shows exerted favorable effects(p=0.05) on vasomotor symptoms and lipid 
profile, showing itself to be an interesting alternative therapy for the 
postmenopausal women. 
Ishiwata N et al. (2009) conducted a randomized double blind placebo 
control trial study on soya bean supplement for relieving menopausal 
symptoms. 134 Japanese women age between 40-59 years. Mood states 
questionnaire was used to collect the data for 12 weeks. Placebo (n=4) 10mg of 
equal per / day (Eq: 1 n = 44) and 10mg of equal three times per day (Eq: 3 
n=46). Habitual isoflavones intake was limited to 20mg/dl. The result of the 
study was compared with placebo, the EQ-3 group showed significant 
decreases in depression scores (P < 0.05), as well as significant decreases in 
Tension-Anxiety (P < 0.05), Depression-Dejection (P < 0.05) and Fatigue (P < 
0.01) and increases in Vigor (P < 0.05) of the Profile of Mood States, hot 
flushes.  The study concluded that Soya supplement improved mood-related 
symptoms in perimenopausal/postmenopausal equal non producers. 
Albertazzi et al. (2009)conducted a randomized, double-blind, placebo-
controlled trial to assess the effect of daily dietary supplementation of soy 
protein isolate powder on hot flashes in postmenopausal women.46 Age in the 
treatment group (n=51) was 48-61 years, while in the control group (n=53) it 
  
ranged from 45-62 years. The diets of the 104 women were supplemented with 
either 60 g soy powder (40 g isolated soy protein) or 60 g placebo (casein) 
daily for 12 weeks. By the end of the 12th week, women taking the soy protein 
isolate had a 45% reduction in daily hot flashes compared to a 30% reduction 
obtained with the placebo. It was concluded that Soy protein isolate added 
daily to the diet substantially reduced the frequency of hot flushes in 
climacteric women 
.  Soundari (2009) conducted a comparative study among 40 menopausal 
women, the effectiveness of soya bean versus diaphragmatic breathing 
exercise. Mean difference between pre and post test menopausal problem score 
in experimental group I and experimental group II was 2.95, t =6.210. (0.001) 
was highly significant. There was significant relief in menopausal problem 
among working women in soya group than diaphragmatic breathing group. 
Professor Melby (2009) examined the impact of isoflavones ± the 
chemicals found in soya that produce an effect similar to estrogen. She said that 
ingesting at least 54mg of soya is flavones daily for six weeks to a year reduces 
the frequency of hot flushes by 20.6 per cent and severity by 26 per cent. Each 
gram of soya protein in soya beans and traditional soya foods provides 
approximately 3.5mg of isoflavones. Two glasses of soya milk provide 
approximately 50mg of isoflavones. 
Francine k.Welty et al. (2009) conducted an epidemiological study to 
examine the effect of soy nuts on hot flashes and menopausal symptoms. Sixty 
healthy postmenopausal women were randomized in a crossover design to a 
therapeutic lifestyle changes diet alone and a TLC diet of similar energy, fat, 
and protein content in which one-half cup soy nuts divided into three or four 
portions spaced throughout the day replaced 25 g of nonsoy protein.  The result 
of the study was 19% decrease in vasomotor score), 12.9% reduction in 
psychosocial score), 9.7% decrease in physical score, and a trend toward 
improvement in the sexual score, with a 17.7% reduction in symptoms.  The 
  
study was concluded that substituting soy nuts for nonsoy protein in a TLC diet 
and consumed three or four times throughout the day is associated with a 
decrease in hot flashes and in reducing menopausal symptoms. 
Borchers (2008) conducted study to find effectiveness of soy 
isoflavones modulate immune function in healthy post menopausal women. 
Post menopausal women aged 50-65 year enrolled in this 16 weeks double 
blind, placebo controlled trial were randomly assigned to 1 of 3 experimental 
group: 1) control, 706ml cow milk/day plus a placebo supplement 2) Soy milk, 
71.6mg isoflavones derived from 706ml soy milk/day plus a placebo 
supplement 3) Supplement, 70mg isoflavones in a supplement plus 706 ml cow 
milk/day. Plasma and 24 hrs urine sample were obtained at baseline and at 16 
weeks. The researcher concluded that soy milk and supplemental isoflavone 
modulate. 
Khaodhiar et al. (2008) conducted study among 147 post menopausal 
women given daily supplements of the diadze in rich isoflavon eaglycone 
supplement at a dose of 40 or 60mg for 12 weeks. At the end of the study, the 
researcher report that the number of hot flashes in the group receiving the 
lower dose was reduced by 52%, while the women receiving the higher dose 
experienced 51% reduction of in number of hot flushes. The placebo group 
reported as 39% reduction in hot flush frequently. The study concluded that 
supplements of diadzein rich isoflavone has reduced hot flushes among post 
PHQRSDXVDOZRPHQ¶VS  
G Radhakrishnan et al. ( 2008) conducted a double blind, placebo 
controlled trial study to examine effects of 6 months supplementation of 
isoflavone rich soy protein on symptoms, lipid profiles and bone density in 
postmenopausal women. 100 healthy postmenopausal women, not taking 
Hormone Replacement Therapy, were randomly assigned to consume either 
25gm soy protein isolate containing 75 mg isoflavones (study group) or 25 gm 
casein protein (control group) daily. Significantly higher number of cases 
  
reported improvement in hot-flashes, joint-pains and vaginal-dryness on soy 
treatment (p<.05). Soy group showed 7.7% decrease in total cholesterol and 
14% decrease in LDL-cholesterol(significantly different from control group 
p<.05) while no effect was seen on HDL cholesterol, Blood pressure, sex 
hormones, vaginal cytology, uterine endometrium & bone densitometry.  It is 
concluded that 25gm soy supplement containing 75mg of isoflavones may be 
an effective alternative therapy for menopausal symptoms and may offer a 
benefit to cardiovascular-system by altering lipid-profile favorably. 
Lakshmi k.s, (2010) conducted a study in selected villages of 
Coimbatore district, Tamilnadu to assess the effectiveness of soya bean 
consumption on menopausal symptoms among women between 45-5 years. 
The study results reveal that post-assessment mean 11.5 was lesser than 
SUHDVVHVVPHQW PHDQ LQ H[SHULPHQWDO JURXS 7KH REWDLQHGµW¶ YDOXH 
was highly significant at 0.05 level. The investigator concluded that soya milk 
consumption was effective on menopausal symptoms.    
Jeinkins (2007) conducted an experimental study  by twenty-five 
hyperlipidemic men and women took soy (providing 36 g/d soy protein and 
168 mg/disoflavones) and control breakfast cereals, each for 3 weeks in a 
randomized cross over study with a 2-week washout period between 
treatments. Fasting blood samples were obtained pretreatment and at weeks 2 
and 3 of each treatment. However, oxidized low-density lipoprotein (LDL) was 
reduced on the test compared with the control both as total dienes in LDL. 
Consumption of soy protein may reduce the risk of cardiovascular disease both 
through reduction in serum lipids and by the antioxidant properties of protein-
associated soy isoflavones. 
  Misra et al. (2003) conducted a randomized clinical trial to evaluate 
the efficacy of herbo mineral on menopausal syndrome. Postmenopausal 
syndrome is characterized by manifestations of hot flushes, insomnia, night 
sweating, irritability and mood swings and anxiety-depression. M-3119, a 
  
herbo mineral preparation administered to 42 women with  signs and symptoms 
of postmenopausal syndrome at a dose of 2 tablets twice daily for 6 months, 
cured the symptoms in 53% of women, improved in 31% and remaining 16% 
did not respond to the therapy. From the various parameters taken for clinical 
analysis, it may be concluded that M-3119 would be an effective therapy for 
the control of symptoms of menopausal syndrome. 
Somekawa (2007) conducted study to investigate the influence of soy 
isoflavones on menopausal symptoms, bone mineral density in post 
menopausal women. In total 478 postmenopausal women were involved in the 
study. After selection, they were divided in four groups depending on quantity 
of daily isoflavones consumption... The women had menopause symptoms at 
the time of enrolment such as hot flushes, sweating, chills, sleep problems, 
irritability depression, headaches, palpitations and backache. The average 
(mean) daily intake of soy isoflavones was 54.3mg. The study concluded that 
high consumption of soy isoflavones is associated with increased bone density 
in postmenopausal women (p=.02). Consumption of soy isoflavones might be 
useful to prevent symptoms related with low estrogen levels. 
Shah & Agarwal (2006)   in a public hospital in India conduced a 
prospective, randomized, double blind, placebo- controlled trial to   evaluate 
the effects of a herbo mineral phytoestrogen formulation [drug A] containing 
soy isoflavones in 60 peri and post menopausal women with menopausal 
symptoms .women with symptoms related to menopause were randomized and 
assigned to either group A or group B (placebo).. The group that received the 
active drug showed 40% of improvement in psychological symptoms as 
compared to the placebo group. This group also reported an overall sense of 
well being as compared to the placebo group. 
Malhotra (2004) described that isoflavones are plant compounds that 
are structurally and functionally similar to 17 -oestradial and bind to oestradial 
receptors despite relatively weak estrogen receptors binding potencies, 
  
isoflavone have bioactivity similar to that of oestradial and reach concentration 
sufficient to elicit response in the human body. 
Albertazzi, et al. (2003) conducted a randomized, double-blind, 
placebo-controlled trial was conducted to assess the effect of daily dietary 
supplementation of soy protein isolate powder on hot flashes in 
postmenopausal women. Age in the treatment group was 48-61 years, while in 
the control group it ranged from 45-62 years. The diets of the 104women were 
supplemented with either 60 g soy powder (40g isolated soy protein) or 60 g 
placebo (casein) daily for 12 weeks. By the end of the 12th week, women 
taking the soy protein isolate had a 45-percent reduction in daily hot flashes 
compared to a 30-percent reduction obtained with the placebo.                           
2.2 Conceptual Framework 
. The present study is aimed at assessing the effectiveness of soya milk upon 
reduction of menopausal symptoms among menopausal women at selected 
areas at Chennai. 7KH FRQFHSWXDO IUDPHZRUN RI WKH VWXG\ZDV:HLGHQEDFK¶V
Helping art theory. 
This Theory Has 3 Factors 
   1) Central purpose 
   2) Prescription 
   3) Realities 
1) Central purpose 
       It refers to what the nurse wants to accomplish. It is the overall goal 
towards which a nurse strives.  
2) Prescription 
  
       It refers to the plan of care for clients. It will specify the nature of action 
WKDWZLOOIXOILOOWKHQXUVH¶VFHQWUDOSXUSRVH 
3) Realities  
 It refers to the physical, physiological, emotional and spiritual factors that 
come into play in situation involving nursing action. The five realities 
LGHQWLILHGE\ZLHGHQEDFK¶VDUHDJHQWUHFLSLHQWJRDOPHDQVDQGIUDPHZRUN 
       The conceptual framework of the nursing practice according to this theory 
consists of three steps as followed: 
Step I:   Identifying the need for help 
Step II:  Ministering the needed help 
Step III: Validating that the need for help was met 
Step-I: Identifying the need for help 
    This step involves determining the need for help. The menopausal women 
with menopausal symptoms are identified by screening with Modified Wiklund 
Menopausal Scale. The random sampling method by lottery metho is used to 
select the sample. 
Pre Interventional level of menopausal symptoms is measured using combined 
demographic data and Modified Wiklund Menopausal scale. 
Step-II: Administration of the needed help 
After the pre assessment levels of menopausal symptoms are measured,    
This refers to the provision of required help to fulfill the identified need. It has 
two components 
 Prescription 
  
 Realities 
Prescription 
In this study prescription refers to soyamilk administration. 
Realities 
Agent         :  Investigator 
Recipient    :  Menopausal women (40 -60 years) 
Goal           : Reducing the postmenopausal menopausal          ,                       
symptoms 
Means         :  100ml of Soya milk administration 
Framework : Menopausal Women residing at selected urban area Choolai, 
Chennai-112 
Step-III: Validation of the need for help was met 
It is accomplished by means of measuring post assessment level of menopausal 
symptoms after soya milk administration. This was done by Modified Wiklund 
Menopausal Scale and identified whether there is a reduction of menopausal 
symptoms among women. 
       
 
       
 
       
 
          
   2.
2 
 D
K

/&
/

t
/

E

,
͛^
,
>
W/
E
'
Z
d
d,
K
Zz
 
W
om
en
 3
0 
in
 co
nt
ro
l 
gr
ou
p 
w
ith
 sy
m
pt
om
s 
Ro
ut
in
e 
ca
re
 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
  W
IK
LU
N
D
 M
EN
O
PA
U
SE
 R
AT
IN
G 
SC
AL
E 
C
E
N
T
R
A
L
 P
U
R
PO
SE
: T
o 
re
du
ce
 th
e 
se
ve
rit
y 
of
 m
en
op
au
sa
l s
ym
pt
om
s a
m
on
g 
po
st
 m
en
op
au
sa
l w
om
en
 V
A
LI
D
A
TI
N
G
 T
H
E 
M
ET
 N
EE
D
S 
ID
EN
T
IF
Y
IN
G
 T
H
E 
N
E
E
D
 
FO
R
 H
E
L
P 
M
IN
IS
T
E
R
IN
G
 T
H
E 
N
EE
D
 F
O
R
 
H
E
L
P 
N
U
R
SI
N
G
 
PR
A
C
T
IC
E
  
(R
ea
lit
ie
s)
 
A
ge
nt
:  
In
ve
st
ig
at
or
 
R
ec
ip
ie
nt
: P
os
t 
M
en
op
au
sa
l w
om
en
 
G
oa
l: 
R
ed
uc
in
g 
th
e 
se
ve
rit
y 
of
 
m
en
op
au
sa
l 
sy
m
pt
om
s  
M
ea
ns
: s
oy
a 
m
ilk
 
ad
m
in
ist
ra
tio
n 
Po
st
 
m
en
op
au
sa
l 
w
om
en
 w
ith
 
ph
ys
ic
al
 a
nd
 
ph
ys
io
lo
gi
ca
l 
sy
m
pt
om
s. 
P O
   
 
S T
  A
 S S E
 S S M E
 
N
 T
 
P R
 
E
  A
 S S E
 S S M
 
E
 
N
 
T
   
W
om
en
 w
ith
 
po
st
 
m
en
op
au
sa
l 
sy
m
pt
om
s 
 
(3
0 
)in
 
ex
pe
rim
en
ta
l 
gr
ou
p 
PR
E
SC
R
IP
T
IO
N
 
A
dm
in
is
tra
tio
n 
of
 
so
ya
m
ilk
 1
00
m
l 
( 5
0g
m
s  
of
 so
ya
 
be
an
s i
n 
10
0m
l 
of
 w
at
er
 w
ith
 5
m
l 
of
 h
on
ey
) o
nc
e 
in
 
th
e 
m
or
ni
ng
 
M
A
X
IM
U
M
   
  
O
U
T
C
O
M
E
 
Si
gn
ifi
ca
nt
 
re
du
ct
io
n 
of
 
se
ve
rit
y 
of
 
m
en
op
au
sa
l 
sy
m
pt
om
s 
M
IN
IM
U
M
   
 
O
U
T
C
O
M
E
 
N
o 
re
du
ct
io
n 
in
 se
ve
rit
y 
of
 
m
en
op
au
sa
l 
sy
m
pt
om
s 
  
                                                CHAPTER III 
                                  RESEARCH METHODOLOGY  
The methodology of research study is defined as the way the data are gathered 
in order to answer the question to analyze the research problem. The research 
methodology involves a systemic procedure by which the researcher starts from 
initial identification of the problem to its conclusion.  
The present study conducted to assess the effectiveness of soya milk upon 
menopausal symptoms among menopausal women. The chapter deals in brief 
description of different steps undertaken by the researcher for the study. It 
involves research approach, the setting, population, sample and sampling 
technique, selection of the tool, content validity, reliability, pilot study, data 
collection procedure and plan for data analysis.  
3.1   Research Approach 
An experimental research is the most significant part of any research. The 
appropriate choice of the research approach depends upon the purpose of the 
research study which is under taken. The research approach used in this study 
is quantitative research approach. 
. To accomplish the objective of this study an experimental approach is 
considered most appropriate; since the researcher wanted to assess the 
effectiveness of soya milk upon menopausal symptoms among menopausal 
women.  
3.2 Data collection period: 
The study was conducted for the period of four weeks  
(July 16th to August 15th   2015 ). 
 
  
3.3 Study setting 
 Study was conducted in selected urban areas of choolai. Choolai belongs 
to Chennai corporation which covers 10 zones..Choolai was the north zone and 
our adopted area belongs to 6th  zone.it has 16 streets and covers 58,744 
population. Ckp street, v.v.koil steet, angalparameshwari street were sselected 
for experimental group and periyathambi street, t.k.mudhali street, arimuthu 
mesthri street were selected for control group.the setting selected was just 3 
kms away from our college  and selected based on the feasibility and 
availability.  
3.4 Study Design  
A research design is the overall plan for addressing a research question, 
including specification for enhancing the study integrity.  
CR       O1                                      O2 
ER       O1                         X                      O2 
R - Randomization  
O1- Pre assessment of menopausal symptoms  
O2 - Post assessment of menopausal symptoms  
X -Intervention (administration of soya milk)  
E-Experimental group 
C-Control group. 
An experimental research design was adopted for conducting this study. It 
fulfills the criteria such as manipulation, control, and randomization. 
Randomization was carried out to select the 60 sample and to assign the control 
  
and experimental group. Soya milk was given as manipulation in experimental 
group.  
In this study pretest, posttest control groupdesign was adopted. The researcher 
assessed the prevalence of menopausal symptoms among post menopausal 
women using rating scale on menopausal symptoms. Then control and 
experimental group were selected then manipulated the independent variable 
that is soya milk which was administered only to the experimental group. Then 
the menopausal symptoms were assessed by rating scale for both groups. 
Finally, 
 the effectiveness of soya milk upon menopausal symptoms assessed by using 
rating scale on level of satisfaction.  
 
RANDOM            Experimental                Pretest         soya milk administration                       
,                                                                                                    post test 
SAMPLING            Control                          pretest                       post test 
3.5 Study Population 
The population of the present study comprised of 60 post menopausal 
women with in the age group of 40-60 years in areas of Choolai. Chennai. 
Population 
Population is the entire aggregation of cases which meet designated set 
of criteria. Choolai total population is around 58,744. 
The target population is the group of population that the researcher aims to 
study and to whom the study finding will be generalized. In this study the 
target population for this study comprises of post menopausal women at 
selected urban community areas in Choolai.  
  
Accessible population is the list of population that researcher finds in the 
study area. The accessible population in this study is post menopausal women 
40-60 yrs with menopausal symptoms residing in Choolai. 
3.6 Sample Size: 
 A sample size of 60post menopausal women between 40-60 yrs at selected 
urban community areas in choolai. 30 samples will be assigned for the 
experimental group and 30 for the control group.  .  
3.7 Sampling criterion: 
The sample selected was based on the following inclusion and exclusion 
criteria.  
3.7.1 Inclusion Criteria:  
  Post menopausal women with menopausal symptoms. 
 Study includes women age group 40-60 yrs. 
 Patients who speak and understand, Tamil or English. 
 Women who are all willing to participant in this study. 
3.7.2 Exclusion criteria: 
¾ Study excludes women allergic/intolerance to soya beans. 
¾ clients who were not available during data collection 
¾ Clients who are in hormonal therapy to reduce menopausal symptoms. 
3.8 Sampling Technique 
¾  Sampling techniques:-simple Random sampling method. 
             Simple random sampling technique was used by lottery method. 
The investigator conducted a survey in Choolai to identify the total 
  
number of subjects with menopausal symptoms. In Choolai area 10 
streets were surveyed and the total number of postmenopausal women  
were 264. women obtained from selected areas of Choolai. with 
menopausal symptoms was 174. Women who attained natural 
menopause is 255 and 9 were by surgery. The required 60 number of 
samples with menopausal symptoms each 30 for experimental and 
control group was selected as the sample.  
3.9 Research variables: 
An abstract concept when defined in term that can be measured is called 
a variable. Variables are characteristics that vary among the subject being 
studied.  
Independent variable ± Soya milk 100ml with 5 ml of honey/day for 2 weeks. 
Dependent variable- perceived level of menopausal symptoms among post 
menopausal women. 
3.10 Development  & Description of the tools: 
3.10.1 Development of tool: 
A structured interview schedule was developed based on the objectives of the 
study. Various sources of literature and opinion from the Subject experts are 
obtained to ascertain the effectiveness and to bring out the correct items in the 
questionnaire. All these helped ultimately in developing the tool. 
3.10.2 Description of the tool: 
           The instrument used in this study consists of two sections,  
SECTION A- Demographic profie: - educational status, religion, 
occupation, income, marital status, type of the family, number of children of 
post menopausal women, it consists of 11 questions. 
  
SECTION B- Wiklund Menopausal Symptom Scale. This consists of 10 
menopausal symptoms scale in which the symptoms were assessed using this 
scale and the scoring will be given. It has 10 menopausal symptoms rated on a 
scale of 0-10; where (0 ± none and 10 ± maximum). 
x Sweats 
x Hot flushes 
x Sleep disturbances 
x Fatigue 
x Vaginal dryness 
x Head ache 
x Irritability 
x Muscle/joint pain 
x Breast tenderness 
x Palpitation 
Frequently-3                       
Occasionally-2 
Rarely-1 
Never-0 
SCORE 
 No 
symotoms 
0 0% 
Mild  1 1%-50% 
Moderate  2 51%-75% 
 severe  3 76%-100% 
  
3.10.3 Content Validity : 
Content validity of the tool was obtained by getting opinion from seven 
H[SHUWV%DVHGRQWKHH[SHUW¶VVXJJHVWLRQVWKHUHVHDUFKHUILQDOL]HGWKHWRROVIRU
the original study.  
After construction of questionnaire for ³A study to assess the effectiveness 
of soya milk with honey consumption on reducing physical and physiological 
symptoms  among the post menopausal women with in age group 40-60yrs at 
choolai. Chennai.´ It was tested for its validity and reliability.  
Validity of the tool was assessed using content validity. Content validity was 
determined by experts form Nursing and Medical and statistical expert. They 
suggested certain modifications in tool. After the modifications they agreed this  
tool for evaluate the effectiveness  of soya milk with honey consumption on 
reducing physical and physiological symptoms  among the post menopausal 
women with in age group 40-60yrs at choolai. Chennai. 
After pilot study reliability of the tool was assessed by using split half method 
and its correlation coefficient r ±value was 0.78 .This correlation coefficient is 
very high and it is good tool for evaluate the effectiveness of soya milk with 
honey consumption on reducing physical and physiological symptoms among 
the post menopausal women with in age group 40-60yrs at Choolai, Chennai. 
3.11 Ethical Consideration: 
                   Formal permission and approval obtained from the Institutional 
Ethics committee of Madras Medical College Chennai, before conducting the 
study. No ethical issues aroused during the course of the study. 
3. 12 Pilot Study: 
It is a small scale version done in preparation for a major study. The 
purpose is to find out the feasibility and practicability of study design. The pilot 
study was conducted in the month of June, to assess the feasibility and 
  
practicability to conduct the study. The data was collected using study 
instruments.  
Protection of Human Rights  
x The study was conducted after obtaining clearance from ethical committee,  
Madras Medical College, Chennai, and permission from the research and 
medical guide.  
x Consent was obtained from all participants before data collection.  
x Confidentiality was maintained throughout the study.  
x In order to test the feasibility of the study, a pilot study was conducted 
among six subjects in the same manner as final study. Post Menopausal 
women with Menopausal symptoms (six in number) were selected using 
a simple random sampling technique. They were assessed for 
Menopausal symptoms on the first day using the research tools.  
x              After the pre assessment, 50gms of soya milk was given day for 
20 consecutive days. At the end, on the 21ST day, the subjects were 
assessed again for Menopausal symptoms using the research tool. The 
tool was found to be satisfactory in terms of simplicity and clarity. 
Based on the findings of the pilot study it was concluded that it was 
feasible and practicable to conduct the main study and criterion 
measures were found to be effective. As per the feasibility of the study 
was planned. Pilot study samples are excluded in the main study. 
Reliability 
Instrument 1: Rating scale on menopausal symptoms  
                        The reliability of the rating scale on menopausal symptoms was 
elicited by test -UHWHVWPHWKRGDQG.DUO3HDUVRQµU¶ZDVFRPSXWHGIRU ILQGLQJ
out the reliDELOLW\³U´ZDVIRXQGWREH .Positive correlations indicates that 
the tool was highly reliable.  
  
3.14 Data Collection Procedure: 
Procedure: 
Permission will be obtained, from City Health Officer, survey was done, and 
number of postmenopausal mothers was identified through the survey. Samples 
with symptoms are identified and selected through random sampling. The 
procedure was explained, confidentiality and consent obtained, from samples  
after explaining about the tools . About5 mins for each client was spent for 
each client respectively . 
Preparation: 
1. Soak 1500 gm of soya bean in water the previous night 
2. The next day morning pour 3000ml of water and blend thoroughly using mixie. 
3. The extract of soya milk should be taken by filtering it in a cheese cloth. 
4. The obtained extract must be boiled for a while (10min). 
5. After it is cooled, about a teaspoon-150ml of honey should be added for flavor 
and must be administered. 
Intervention protocol: 
protocol Experimental group Control group 
place 
Client house inSelected 
areas of Choolai 
Selected house in areas 
of Choolai 
Tool  
Soya milk 100ml with 
5ml of honey  
Routine care 
duration 
14 days 14 days 
frequency 
Once a day - 
Time  
Mid morning - 
Administerd 
by 
Investigator self 
 
  
3.15 Data Entry and Analysis: 
After the data collection, the collected data were organized, tabulated, 
summarized, and analyzed. The data will be analyzed according to the 
objectives of the study using descriptive and inferential statistics. 
Descriptive Statistics:  
Frequency, Percentage Distribution, Mean, Standard deviation and 
coefficient of variation will be used for calculating the demographic variables 
Inferential Statistics:   
x 3DLUHG ³W´ WHVWZLOO EH XVHG WR DQDO\]H SUH- test and post- test level of 
menopausal symptoms in experimental and control group. 
x ,QGHSHQGHQW ³W´ WHVW ZLOO EH XVHG Wo compare the level of menopausal 
symptoms and to calculate the effectiveness of the study among 
experimental and control group. 
x Chi squire test will be used to find the association between pre-test level 
of menopausal symptoms and selected demographic variables among 
experimental and control group. 
 
 
 
 
 
 
 
  
                               Experimental study 
 
                                       Quantitative Approach 
 
                                      Pre test post test design 
 
            
           
ACCESSEBLE POPULATION: post menopausal women with menopausal symptoms 
with in the age 40-60 yearsin selected areas of Choolai. 
 
 
PHASE I:SAMPLING TECHNIQUE: simple random sampling 
 
  
PHASE II:Data collection-60 post menopausal women with menopausal symptoms 
Data collection tool: structured questionnaire and menopausal rating scale 
 
 
Experimental group -30 
 
 
Pre assessment of menopausal 
symptoms 
 Pre     assessment of menopausal 
symptoms 
 
Administration of soya milk 100 ml 
with 5 ml of honey once a day daily 
in the mid morning for 14 days 
  
    Routine  care for symptoms 
 
 
 
Data analysis and interpretation through descriptive and inferential 
statistics  
 
        Report and Findings 
                                3.1schematic representation of the    study 
Control group-30 
Reassessment of menopausal symptoms 
Target population post menopausal women with 
  
 
CHAPTER IV 
Data Analysis and Interpretation 
This chapter includes both inferential and descriptive statistics. Statistics is a 
field of study concerned with techniques or methods of collection of data 
classification, summarizing interpretation, drawing inferences, testing of 
hypotheses, making recommendation etc. (Mahajan 2008).  
The data was collected from 60 menopausal women with menopausal 
symptoms. 30 in the control group and 30 in the experimental group to assess 
the effectiveness of soya milk upon menopausal symptoms among women 
residing at selected community area, Choolai, Chennai. 
 Data were analyzed based on the objectives and hypotheses of the 
study. Data analysis was computed after transferring the collected data into a 
coding sheet. The researcher used descriptive and inferential statistics for the 
analysis.  
The data tabulated, analyzed and interpreted using descriptive and 
inferential statistics in the sequence as follows:  
    4.1Organization Of Data 
The findings of the study were grouped and analyzed under the following 
sections. 
Section- A :  
Frequency and percentage distribution of demographic variables of post 
menopausal women in experimental and control group. 
 
 
  
Section ± B: 
Assessment of pre test level of menopausal symptoms among post menopausal 
women in the experimental and control group. 
Section- C   :  
Assessment of post test of menopausal symptoms level among women in the 
experimental and control group. 
Section-D:  
Compare the experimental and control group among post menopausal women. 
Section- E : 
Effectiveness of soya milk on menopausal symptoms among post menopausal 
women in experimental group. 
Section ±F: 
Association between the level of menopausal reduction and their demographic  
variables among women in experimental group and control group. 
4.2 statistical analysis: 
x Demographic variables in categorical/dichotomous were given in 
frequencies with their percentages., Symptoms scores were given in 
mean and standard deviation. 
x Association between symptom reduction score and demographic 
variables were analysed using chi square test. 
x Difference between experiment and control group symptoms score was 
analyzed using independent t-test 
x Difference between pretest and posttest was analysed using student 
paired t-test. 
x Multiple bar diagram and Boxplot were used to represent the data. 
x P<0.05 was considered statistically significant. 
  
Section A:  frequency and percentage of demographc variables of postmenopausal women 
Table 4.1: distribution of demographic variable with post menopausal women 
 Demographic variables 
   
    
           Chi square test 
ExperimentGroup ControlGroup 
frequency In  % frequency In  % 
Age 40 -45 years 2 6.7 4 13.3 F2=2.29 P=0.51  
DF=3   46 -50 years 11 36.7 12 40.0 
 51 -55 years 14 46.6 9 30.0 
 56 -60 years 3 10.0 5 16.7 
Religion Hindu 14 46.7 21 70.0 F2=3.65 P=0.16  
DF=2   Muslim 7 23.3 5 16.7 
 Christian 9 30.0 4 13.3 
Education Illiterate 5 16.7 6 20.0 F2=2.09 P=0.55  
DF=3   Primary 14 46.7 18 60.0 
 Middle school 6 20.0 3 10.0 
 High school 
and above 5 16.6 3 10.0 
Occupation Home maker 20 66.6 22 73.3 F2=2.49 P=0.47  
DF=3   Govt 
employment 2 6.7 3 10.0 
 Private 
employment 2 6.7 3 10.0 
 Self 
employment 6 20.0 2 6.7 
Income < Rs.3000 5 16.6% 4 13.3 F2=4.37 P=0.22  
DF=3   Rs.3000-5000 2 6.7% 3 10.0 
 Rs 5000-
10000 9 30.0% 3 10.0 
 > Rs.10000 14 46.7% 20 66.7 
Dietary 
habits 
Vegetarian 4 13.3% 3 10.0 F2=0.16 P=0.68  
DF=1  
 Non 
Vegetarian 26 86.7% 27 90.0 
Marital status Married 19 63.4% 20 66.7 F2=0.08 P=0.98 
DF=2   Unmarried 1 3.3% 1 3.3 
 Widow 10 33.3% 9 30.0 
No. of 
children 
One 7 23.3% 13 43.3 F2=2.82 P=0.24  DF=2  
 Two 15 50.0% 12 40.0 
 > Two 8 26.7% 5 16.7 
Medical 
illness 
Asthma 1 3.3% 0  0.0 F2=1.07 P=0.31  
DF=1  
 Other   
diseases 29 96.7 30 100.0 
Menopause 
age 
40-45 yrs 8 26.7 11 36.7 F2=2.49 P=0.29  DF=2  
 46-50 yrs 18 60.0 12 40.0 
 51-55 yrs 4 13.3 7 23.3 
Under any 
treatment 
Yes 2 6.7 5 16.7 F2=1.45 P=0.22  
DF=1  
 No 28 93.3 25 83.3 
There is no statistically significant variation with demographic variable 
between experimental and control group.Table  shows the demographic 
information of post menopausal women those who are participated  in this 
  
VWXG\RQ³$VWXG\WRDVVHVVWKHHIIHFWLYHQHVVRIVR\DPLONZLWKKRQH\ 
consumption on reducing physical and physiologial symptoms  among the post 
menopausal women with in age group 40-60yrs at Choolai. CKHQQDL´%RWK
groups are equally distributed. 
Among the study participants, 
In regard to age,  In experimental group 2(6.7%) of women were with in  
the age group of 40-45 years, 11(36.7%) were between 46-50 years, 14(46.6%) 
were within 51-55 years and 3(10.0%) were within 56-60 years respectively. In 
control group,4(13.3%) were with in age group of 40-45 years, 12(40.0%) were 
with in 46-55 years, 9(30.0%) were within 56-60 years. 
                In experimental group, regarding to  religious status majority of 
them 14(46.7%)  and in control group 21(70.0%) are  Hindu.  
         regarding  educational status  , majority of samples14(46.7%) in 
experimental group   and 18(60.0%) in control group  were primarily educated.          
In regard to occupation, majority in experimental group 20(66.7%)  and 
in control group 22(73.3%) were  home maker. 
        Regarding income, 14(46..7%) in experimental group and 20(66.7%) in 
control group earns a monthly income of above 10,000 only, and they all 
belongs to a middle class family. 
       Regarding diertary pattern , in experimental group, 26(86.7%) and in 
control group 27(90.0%) are non vegetarians. 
      In experimental group, 19 63.4%, and in control group 20 66.7% were 
married. 
       In experimental group, majority of women 15(50.0%) have 2 children and 
in control group 13(43.3%) majority were with only 1 children.  
      About 29(96.0%) in experimental group and 30(100.0%) in control group 
have other type of illness like asthma or diabetes or hypertension. 
       Regarding menopausal attainment age, 18(60.0%) in experimental group 
and 12(40.0%) were under the age group 46-55years. 
       About 28(93.3%) in experimental group and 25(83.3%) in control group 
were under no treatment. 
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Section B: assessment of pretest level of menopausal symptoms among the post 
menopausal women in the experimental and control group 
Objective 1: To assess the pre test  level of menopausal symptoms among postmenopausal 
women in experimental group and control group 
 
  Table 4.2: each domain wise pretest percentage of 69enopausal symptoms score 
symptoms 
Maximum  
score Mean SD 
% of menopausal  
symptoms  
 Experiment hot flushes 3 2.20 1.03 73.3 
sleep distribution 3 2.17 0.75 72.3 
night sweats 3 1.73 1.08 57.7 
fatigue 3 1.90 0.92 63.3 
vaginal dryness 3 .93 1.01 31.0 
headache 3 1.47 1.14 49.0 
irritability 3 2.07 0.78 69.0 
joint discomfort 3 1.90 0.88 63.3 
breast tenderness 3 1.40 1.00 46.7 
palpitation 3 1.40 0.72 46.7 
  Total 30 17.17 2.80 57.2 
 Control hot flushes 3 2.23 0.97 74.3 
sleep distribution 3 2.13 0.78 71.0 
night sweats 3 1.63 1.13 54.3 
fatigue 3 1.87 0.94 62.3 
vaginal dryness 3 0.90 1.03 30.0 
headache 3 1.40 1.13 46.7 
irritability 3 1.93 0.91 64.3 
joint discomfort 3 1.87 .90 62.3 
breast tenderness 3 1.37 1.03 45.7 
palpitation 3 1.33 0.76 44.3 
  Total 30 16.67 3.09 55.6 
 
Table  shows each domain wise pretest percentage of menopausal symptoms among 
postmenopausal women in experimental group and control group. In experimental 
group,menopausal symptom with  maximum score was  hot flushes (73.3%) and 
minimum score was vaginal dryness(31.0%). Among control group , the maximum 
score was hot flushes (74.3%) and minimum score was vaginal dryness(30.0%). The 
total mean score in experimental group was 17.17 and control group was 16.67. 
  
 
Section C: Assessment of post test of menopausal symptoms level among women in 
the experimental and control group 
Table 4.3: Pretest  level of menopausal symptoms among postmenopausal women in  
experimental  group and control group 
 Level of symptoms 
 
Group 
Chi square test 
Experiment Control 
frequency  In % frequency  In % 
 Mild 8 26.7 10 33.3 
F2=2.33 P=0.05  
DF=3  
 Moderate 22 73.3 20 66.7 
 Severe 0 0.0 0 0.0 
Total 30 100.0% 30 100.0  
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The table reveals that, 
In pretest, among experiment, 26.7% of the women have mild level of symptoms, 
73.3%  of them have moderate level of symptoms and none of them have severe 
symptoms. Among control, 33.3% of the women have mild level of symptoms, 66.7% 
of them have moderate level of symptoms and none of them have severe symptoms. 
Statistically there is no significant difference between experiment and control group. It 
was confirmed using chi square test. 
Score interpretation 
No symptoms 0 0% 
Mild  15 1%-50% 
Moderate  16-22 51%-75% 
Severe  23-30 76%-100% 
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Objective 2: To assess the  post test level of menopausal symptoms among postmenopausal 
women in control group and  experimental group. 
   Table 4.4: each domain wise post test percentage of post menopasual symptoms score 
symptoms 
Maximum  
score Mean SD 
% of menopausal  
symptoms  
 Experiment hot flushes 3 1.43 .73 47.7 
sleep distribution 3 1.20 .76 40.0 
night sweats 3 .87 .78 29.0 
fatigue 3 1.30 .75 43.3 
vaginal dryness 3 .57 .68 19.0 
headache 3 .77 .68 25.7 
irritability 3 1.07 .69 35.7 
joint discomfort 3 1.40 .72 46.7 
breast tenderness 3 .60 .56 20.0 
palpitation 3 1.07 .78 35.7 
  total 30 10.27 2.84 34.2 
 Control hot flushes 3 2.10 1.06 70.0 
sleep distribution 3 1.97 .89 65.7 
night sweats 3 1.50 1.22 50.0 
fatigue 3 1.73 1.08 57.7 
vaginal dryness 3 .80 1.03 26.7 
headache 3 1.33 1.18 44.3 
irritability 3 1.90 1.03 63.3 
joint discomfort 3 1.77 1.01 59.0 
breast tenderness 3 1.20 1.10 40.0 
palpitation 3 1.20 .85 40.0 
  total 30 15.50 3.35 51.7 
 
Table  shows each domain wise post test percentage of menopausal symptoms among 
postmenopausal women in experimental group and control group. In experiment , the 
total mean score was 1.07(34.2%)  and in control group the mean value was15.50               
( 51.7) respectively.  
 
 
 
 
 
  
 
 
 
 
Table 4.5: posttest  level of menopausal symptoms among postmenopausal women in  
experimental  group and control group 
 Level of 
symptoms 
 
Group 
Chi square test 
Experiment Control 
frequency In  % freuqency in % 
 Mild 
25 83.3 12 40.0 
F2=11.91 
P=0.001***  
DF=1  
 Moderate 
5 16.7 18 60.0 
 Severe 
0 0.0 0 0.0 
Total 
30 100.0 30 100.0  
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In posttest, among experiment, 83.3% of the women have mild level of symptoms, 
16.7%  of them have moderate level of symptoms and none of them have severe 
symptoms. Among control, 40.0% of the women are having mild level of symptoms, 
60.0% of them have moderate level of symptoms and none of them have severe 
symptoms. Statistically there is a significant difference between experiment and 
control group. It was confirmed using chi square test. 
 
 
 
 
   
 
 
fig
ur
e 
4.
13
: p
os
t t
es
t  
le
ve
l o
f m
en
op
au
al
 sy
m
pt
om
 
0%10
%
20
%
30
%
40
%
50
%
60
%
70
%
80
%
90
%
10
0%
M
ild
 
M
od
er
at
e
Se
ve
re
83
.3
%
16
.7
%
0.
0%
40
.0
%
60
.0
%
0.
0%
% of women
po
st
 te
st
 le
ve
l o
f m
en
op
au
sa
l s
ym
pt
om
s
  
Section D: compare the experimental and control group among postmenopausal women 
Objective3: To evaluate the effectiveness of soya milk on menopausal symptoms 
among postmenopausal women in experimental group. 
 
Table 4.6 comparison of pretest and postest mean menopausal symptom score (experiment) 
 
 
Group 
Mean 
 difference 
Student Paired t-test 
Pretest Posttest 
Mean SD Mean SD 
hot flushes 
2.20 1.03 1.43 .73 0.77 
t=3.03 p=0.001***  
sleep distribution 
2.17 .75 1.20 .76 0.97 
t=5.29 p=0.001***  
night sweats 
1.73 1.08 .87 .78 0.87 
t=3.56 p=0.001***  
fatigue 
1.90 .92 1.30 .75 0.60 
t=2.57 p=0.001***  
vaginal dryness 
.93 1.01 .57 .68 0.37 
                 t=1.99 p=0.05*  
headache 
1.47 1.14 .77 .68 0.70 
t=2.57 p=0.001***  
irritability 
2.07 .78 1.07 .69 1.00 
t=4.66 p=0.001***  
joint discomfort 
1.90 .88 1.40 .72 0.50 
t=2.28 p=0.001***  
breast tenderness 
1.40 1.00 .60 .56 0.80 
t=3.78 p=0.001***  
palpitation 
1.40 .72 1.07 .78 0.33 
               t=1.96  p=0.05*  
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On comparing the pre test and post test mean post menopausal symptom score, 
in experimental group , after the consumption of soya milk , there is a statistically 
significant improvement in majority of symptoms. Almost all the symptoms are  very 
highly significant (,p=0.001), except for vaginal dryness and palpitation which is less 
significant(,p=0.05). 
 
 
 
 
 
 
 
  
 
Table 4.7  comparison of pretest and postest mean menopausal symptom score (control) 
 
 
 
Group 
Mean  
difference 
Student Paired t-test 
Pretest Posttest 
Mean SD Mean SD 
hot flushes 
2.20 1.03 2.10 1.06 0.10 
t=0.62 p=0.53  
sleep distribution 
2.17 .75 1.97 .89 0.20 
t=1.90 p=0.07  
night sweats 
1.73 1.08 1.50 1.22 0.23 
t=1.68 p=0.10  
fatigue 
1.90 .92 1.73 1.08 0.17 
t=1.68 p=0.10  
viginal dryness 
.93 1.01 .80 1.03 0.13 
t=1.36 p=0.18  
headache 
1.47 1.14 1.33 1.18 0.14 
t=1.43 p=0.16  
irritability 
2.07 .78 1.90 1.03 0.17 
t=0.25 p=0.80  
joint discomfort 
1.90 .88 1.77 1.01 0.13 
t=1.36 p=0.18  
breast tenderness 
1.40 1.00 1.20 1.10 0.20 
t=1.72 p=0.10  
palpitation 
1.40 .72 1.20 .85 0.20 
t=1.68 p=0.11  
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Table  reveals  the pretest and post test mean difference among the control group. 
Pretest and posttest mean menopausal symptom score among control women was analyzed 
using student paired t-test. Comparing pre and post test in control group, there is no 
significant improvement in menopausal symptom reduction. 
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Table 4.8: comparison of pretest and posttest menopausal symptoms  
among postmenopausal women 
  Symptom score Mean 
difference 
Student paired t-test 
Mean SD 
Experiment pretest 
17.17 2.81 
6.90 t=9.26 p=0.001 
***significant 
posttest 
10.27 2.84 
Control pretest 
16.67 3.08 
1.17 t=1.71 p=0.10 not 
significant 
posttest 
15.50 3.35 
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Table  shows the comparison of overall pretest and posttest. 
Considering experiment group 
The pretest mean score was 17.17 score and the posttest mean score was 10.27 . The  
Difference is 6.90 score.  The difference between pretest and posttest   score is  large and ther 
is a statistically significant improvement. Differences between pretest and posttest  score was 
analyzed  using Student paired-test.  
Considering control group, 
The pretest mean score was 16.67 score and in posttest , the mean score was 15.50. 
Difference is 1.17 score.  The difference between pretest and posttest   score is  small and it is  
not statistically significant. Differences between pretest and post test score was analysed 
using Student paired t-test. 
 
  
 
 
 Figure 4.15 Box-plot compares the pretest and posttest mean menopausal symptoms score 
among experiment and control group of postmenopausal women 
 
 
 
 
 
 
 
 
 
 
  
Table 4.9:comparison of experiment  and control menopausal symptoms  
among postmenopausal women. 
  Symptom score Mean 
difference 
Student independent t-
test 
Mean SD 
Pretest Experiment  
17.17 2.81 
0.50 t=0.66 p=0.51 not 
significant 
Control  
16.67 3.08 
posttest Experiment  
10.27 2.84 
5.23 t=6.52 p=0.001*** 
significant 
Control  
15.50 3.35 
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Table   shows the comparison of overall pretest and posttest. Considering pretest 
Among experimental group, the mean score was 17.17 score and in control , it was16.67 
score. Difference is 0.50 score.  The difference between experiment and control   score was 
small and it is  not statistically significant. Differences between experiment and control  score 
was analysed using Student independent t-test.  
Considering posttest 
Among experiment, women  have 10.27 score and in control , they  have15.50 score. 
Difference is 5.23 score.  The difference between experiment and control   score is  large and 
it is  statistically significant. Differences between experiment and control  score was analysed 
using Student independent t-test. 3ZLWKFRQILGHQFHLQWHUYDO 
.  
 
 
 
  
Section E: Table 4.10: effectiveness of soyamilk with honey consumption on reducing 
physical and physiologial symptoms  among the post menopausal women 
 
  Max 
score 
Mean 
symptoms 
score 
Mean Difference 
in symptom score  
with 95% 
Confidence 
interval 
Percentage  of   
symptom  score 
with 95% 
Confidence 
interval 
Experiment Pretest 30 
17.17 
6.90(5.38 ± 8.42) 23.0%(17.9% ±
28.1%) 
Posttest 30 
10.27 
Control Pretest 30 
16.67 
1.17(0.59 ± 1.75) 3.9%(1.9% ±5.8%) 
Posttest 30 
15.50 
Table no10 shows the effectiveness of soyamilk with honey consumption on reducing 
physical and physiological symptoms  among the post menopausal women. 
On an  average, in experimental group, the net reduction rate of menopausal 
symptoms was 23.0% and in control group it was 3.9% .This shows the effectiveness 
of soya milk with honey consumption. Differences between pretest and posttest  score 
was analysed using percentage with 95% CI and mean difference with 95% CI.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 4.11: each domainwise effectiveness of soyamilk with honey consumption  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table  shows each domain percentage of symptom reduction score 
This shows the effectiveness soyamilk with honey consumption on reducing physical 
and physiological symptoms  among the post menopausal women. 
The overall pre test and post test difference in control group is 3.9% and experimental 
group  it is 23.0%.thus the difference percentage is 23.0%. this shows the effectivenss 
of soya nilk on post menopausal symtoms. 
 
 
 
 
 
            domains Experiment 
In % 
Control  
In % 
pretest posttest difference pretest posttest difference 
hot flushes 
73.3 47.7 25.6 74.3 70.0 4.3 
sleep distribution 
72.3 40.0 32.3 71.0 65.7 5.3 
night sweats 
57.7 29.0 28.7 54.3 50.0 4.3 
fatigue 
63.3 43.3 20.0 62.3 57.7 4.6 
vaginal dryness 
31.0 19.0 12.0 30.0 26.7 3.3 
headache 
49.0 25.7 23.3 46.7 44.3 2.4 
irritability 
69.0 35.7 33.3 64.3 63.3 1.0 
joint discomfort 
63.3 46.7 16.6 62.3 59.0 3.3 
breast tenderness 
46.7 20.0 26.7 45.7 40.0 5.7 
palpitation 
46.7 35.7 11.0 44.3 40.0 4.3 
             overall 
57.2 34.2 23.0 55.6 51.7 3.9 
  
Objective 4: To associate the menopausal symptoms among post menopausal women and 
their selected demographic variables 
Section F:  Table 4.12: association between pretest level of symptom reduction score  and women  
demographic variables(experiment)  
Demographic variables 
 
 
LEVEL OF SYMPTOMS  
REDUCTION SCORE 
Total Chi square test 
Below average 
 
Above average 
(> 6.9) 
frequency in% frequency  in% 
Age 40 -45 years 2 0.0 0 0.0 2 
F2=8.17 P=0.05*  
DF=3  
 46 -50 years 8 72.7 3 27.3 11 
 51 -55 years 4 28.5 10 71.5 14 
 56 -60 years 1 33.3 2 66.7 3 
Religion Hindu 5 35.7 9 64.3 14 
F2=2.28 P=0.32  
DF=2 
 Muslim 4 57.1 3 42.9 7 
 Christian 6 66.7 3 33.3 9 
Education Illiterate 5 100.0 0 20.0 5 
F2=7.49 P=0.05*  
DF=3  
 Primary 7 50.0 7 50.0 14 
 Middle school 2 33.3 4 66.7 6 
 High school and above 1 20.0 4 80.0 5 
Occupation Home maker 9 45.0 11 55.0 20 
F2=4.86 P=0.18  
DF=3  
 Govt employment 1 50.0 1 50.0 2 
 Private employment 0  0.0  2 100.0 2 
 Self employment 5 83.3 1 16.7 6 
Income < Rs.3000 5 100.0 0 0.0 5 
F2=7.70 P=0.05*  
DF=3  
 Rs.3000-5000 1 50.0 1 50.0 2 
 Rs 5000-10000 5 55.6 4 44.4 9 
 > Rs.10000 4 28.6 10 71.4 14 
Dietary habits Vegetarian 1 25.0 3 75.0 4 F2=1.15 P=0.28 
DF=1  Non Vegetarian 14 53.8 12 46.2 26 
Marital status Married 10 52.6 9 47.4 19 
F2=1.05 P=0.59  
DF=2  
 Unmarried 0  0.0  1 100.0 1 
 Widow 5 50.0 5 50.0 10 
No. of children One 1 14.3 6 85.7 7 
F2=4.67 P=0.10  
DF=2  
 Two 9 60.0 6 40.0 15 
 > Two 5 62.5 3 37.5 8 
Medical illness Asthma 0  0.0  1 100.0 1 F2=1.03 P=0.31  
DF=1   Cardiac diseases 15 51.7 14 48.3 29 
Menopause age 40-45 yrs 5 62.5 3 37.5 8 
F2=0.73 P=0.69  
DF=2  
 46-50 yrs 8 44.4 10 55.6 18 
 51-55 yrs 2 50.0 2 50.0 4 
Under any 
treatment 
Yes 
1 50.0 1 50.0 2 F2=0.00 P=1.00  
DF=1   No 14 50.0% 14 50.0 28 
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Table  shows the association between certain demographic variables and the level  of symptoms 
reduction score  .. statistical significance was calculated using chi square test. There is a statistical 
reduction among age, education and income status with the level of menopausal symptoms in post 
menopausal women. 
  
 
 
Table 4.13: association between pretest level of symptom  reduction score  and women  
demographic variables(control) 
demographic variables 
 
 
level of symptoms  
reduction score 
total chi square test 
Below average 
 
Above average 
(> 6.9) 
frequency In % frequency in % 
Age 40 -45 years 3 75.0 1 25.0 4 
F2=2.64 P=0.45 
DF=3  
 46 -50 years 4 33.3 8 66.7 12 
 51 -55 years 5 55.6 4 44.4 9 
 56 -60 years 3 60.0 2 40.0 5 
Religion Hindu 10 47.6 11 52.4 21 
F2=1.24 P=0.54  
DF=2  
 Muslim 2 40.0 3 60.0 5 
 Christian 3 75.0 1 25.0 4 
Education Illiterate 4 66.7 2 33.3 6 
F2=2.22 P=0.53  
DF=3  
 Primary 7 38.9 11 61.1 18 
 Middle school 2 66.7 1 33.3 3 
 High school and above 2 66.7 1 33.3 3 
Occupation Home maker 9 40.9 13 59.1 22 
F2=4.06 P=0.25  
DF=3  
 Govt employment 3 100.0   3 
 Private employment 2 66.7 1 33.3 3 
 Self employment 1 50.0 1 50.0 2 
Income Rs.3000-5000 1 33.3 2 66.7 3 
F2=0.66 P=0.88  
DF=3  
 Rs 5000-10000 2 66.7 1 33.3 3 
 > Rs.10000 10 50.0 10 50.0 20 
 < Rs.3000 2 50.0 2 50.0 4 
Dietary habits Vegetarian 2 66.7 1 33.3 3 F2=0.37 P=0.54 
DF=1   Non Vegetarian 13 48.1 14 51.9 27 
Marital status Married 12 60.0 8 40.0 20 
F2=4.57 P=0.10 
DF=2  
 Unmarried 1  100.0  0 0.0 1 
 Widow 2 22.2 7 77.8 9 
No. of children One 9 69.2 4 30.8 13 
F2=3.45 P=0.17  
DF=2  
 Two 4 33.3 8 66.7 12 
 > Two 2 40.0 3 60.0 5 
Medical illness Asthma 0 0.0 0 0.0 0 F2=0.00 P=1.00  
DF=1   Cardiac diseases 15 50.0 15 50.0 30 
Menopause age 40-45 yrs 5 45.5 6 54.5 11 
F2=0.56 P=0.75  
DF=2  
 46-50 yrs 7 58.3 5 41.7 12 
 51-55 yrs 3 42.9 4 57.1 7 
Under any treatment Yes 4 80.0 1 20.0 5 F2=2.16 P=0.14  
DF=1   No 11 44.0 14 56.0 25 
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Table no 13 shows the association between level  of symptoms reduction score and their 
demographic variables. None of the variables are significant. statistical significance was 
calculated using chi square tests 
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                                    CHAPTER V                                                        
                                  SUMMARY OF RESULTS 
 
The aim of our present study was to evaluate the effectiveness of soya 
milk in reducing the post menopausal symptoms. The study was conducted 
using quasi experimental research design.   
 
Distribution Of Demographic Variable: 
Demographic variables of control and experimental group of menopausal 
women 
 Among the study participants, 
Age:  In experimental group 2(6.7%) women were with in  the age group of 40-
45 years, 11(36.7%) were between 46-50 years, 14(46.6%) were within 51-55 
years and 3(10.0%) were within 56-60 years respectively. In control 
group,4(13.3%) were with in age group of 40-45 years, 12(40.0%) were with in 
46-55 years, 9(30.0%) were within 56-60 years. 
In experimental group, regarding to  religious status majority of them 
14(46.7%)  and in control group 21(70.0%) belongs to Hindu.  
         In experimental group  in regard to educational status  , majority of 
samples are primarily educated 14(46.7%)  and in control group  also 
18(60.0%) studied only till  primary education.  
         In regard to occupation, most of them in experimental group 20(66.7%)  
and in control group 22(73.3%) were  home maker. 
        Regarding income, 14(46..7%) in experimental group and 20(66.7%) in 
control group earns a monthly income of above 10,000 only, and they all 
belongs to a middle class family. 
  
       Regarding diertary pattern , in experimental group, 26(86.7%) and in 
control group 27(90.0%) are non vegetarians. 
      In experimental group, 19 63.4% were married, and 20 66.7% in control 
group were married. 
       In experimental group, majority of women 15(50.0%) have 2 children and 
in control group 13(43.3%) were majority with only 1 children.  
      About 29(96.0%) in experimental group and 30(100.0%) in control group 
have other type of illness like asthma or diabetes or hypertension. 
       Regarding menopausal attainment age, 18(60.0%) in experimental group 
and 12(40.0%) were under the age group 46-55years. 
       About 28(93.3%) in experimental group and 25(83.3%) in control group 
were under no treatment. 
            Majority of the women were home makers hence they were approached 
by community health nurse during her home visit. She should educate about the 
symptoms and reduction measures such as exercise, dietary modification 
including supplementation of soya. In contrast with the hormonal replacement 
therapy natural remedies are cost effective and free of adverse effects. Hence 
the nurse has to motivate the family members to support menopausal women to 
adapt menopausal changes during their menopausal period the family members 
to support menopausal women to adapt menopausal changes during their 
menopausal period. 
5.1 Major Findings Of The Study: 
1. The pre assessment mean value of postmenopausal symptom score for 
experimental group is 17.17 and in control group is 16.67. 
2.  The post assessment mean value of post menopausal score for experimental 
group 10.27 and in control group score 15.50 respectively.  
3. The level of pre menopausal symptoms in experimental group is 26.7% with 
mild postmenopausal symptoms 73.3% had moderate symptoms. 
  
4. The level of pre assessment post menopausal symptoms score in control group 
was 33.3% of women had mild post menopausal symptoms and 66.7% had 
moderate symptoms. 
5. The level of post assessment post menopausal symptom in experimental group, 
83.3% of the women had mild post menopausal symptom and 16.6% had 
moderate post menopausal symptoms. 
6. The level of post assessment post menopausal symptom in control group was 
40.0% of the women had mild menopausal symptoms and 60.0%are had 
moderate symptoms. 
7. 7KH REWDLQHGµW¶ YDOXH RI FRPSDULVRQ RI SUH DVVHVVPHQW SRVWPHQRSDXVDO
symptoms scores for experimental and control group was 0.66 respectively. 
8. The obWDLQHGµW¶ YDOXH RI FRPSDULVRQ RI WKH SRVW W-test post menopausal 
symptom core for experimental and control group was 6.52 respectively. 
9. In experimental group, the reduction score in effectiveness of soya bean 
consumption was 23.0 and in control group it had been increased as 3...9% 
problem free. 
10. Thus, the net benefit of this study in the effectiveness of the soya bean 
consumption in reducing the menopausal symptoms was 23.0%. 
                       .  
 
 
 
 
 
 
 
  
                                              CHAPTER VI 
                                              DISCUSSION 
 
          This study  is discussed as follows, 
           The objectives of this includes, 
To assess the pre test level of menopausal symptoms among postmenopausal women 
in experimental group and control group. 
To assess the post test level of menopausal symptoms among postmenopausal women 
in control group and experimental group. 
To evaluate the effectiveness of soya milk on menopausal symptoms among 
postmenopausal women in experimental group. 
To associate the menopausal symptoms among post menopausal women and their 
selected demographic variables 
Prevalence of menopausal symptoms among menopausal women  
                     As In 2025, India will reach 165 millions. More than 12% of population 
will be above 60 yrs of age, almost 50% of these will be women, a staggering 
population in menopausal & post menopausal age, and 70% of these populations in 
Rural India. In our country the health programmes concentrate only the reproductive 
age group women; the menopausal age is neglected by all. There is great need to 
survey and identify the post menopausal women in our population which will help to 
formulate policies and programmers targeting them. 
                  
 
  
 
Objective 1: To assess the pre test  level of menopausal symptoms among 
postmenopausal women in experimental group and control group 
Each domain wise pretest percentage of menopausal symptoms scores. Was assessed. 
In experiment, maximum score is hot flushes (73.3%) and minimum score is vaginal 
dryness (31.0%). Among control group, is the maximum score is hot flushes (74.3%) 
and minimum score is vaginal dryness (30.0%). 
Pre-test level of menopausal symptoms among postmenopausal women in 
experimental group and control group was assessed. In experimental group, pretest 
mild level symptoms are (26.7%), moderate symptoms (73.3%), whereas in control 
group, pretest mild level symptoms are (33.3%), moderate symptoms (66.7%). The 
chi-square value is 2.33 p=0.05.Statistically there is no significant difference between 
experiment and control group. 
Thus the difference is too small and it is not statistically significant. Thus higher 
proportion in experimental group experience menopausal symptoms. 
The above findings are evident with the Kondagunta Nagaraj et al, (2014)  , he 
conducted a population based cross sectional study on prevalence of menopausal 
symptoms in Mumbai among 500 women age of 40-56 years the study finding reports 
that over 64% menopausal women of 37.4% muscular and joint pain, 35.6% fatigue, 
the other symptoms reported were19.4% hot flush, 18.6% sweating, 20.6% insomnia, 
13.8%,headache and 7.6% of urogenital problems. The study concluded that higher 
proportion of menopausal women suffers from other complaints. The difference 
between the two groups is too small and thus not significant. 
 
 
 
  
Objective 2: To assess the post test level of menopausal symptoms among 
postmenopausal women in control group and experimental group. 
Each domain wise pretest percentage of menopausal symptoms score has been 
assessed. In experiment, maximum score is hot flushes (47.7%) and minimum score is 
vaginal dryness (19.0%). Among control group, is the maximum score is hot flushes 
(70.0%) and minimum score is vaginal dryness (26.7%). 
Post test level of menopausal symptoms among postmenopausal women in 
experimental group and control group were assessed. In posttest, among experiment, 
83.3% of the women are having mild level of symptoms, 16.7% of them are having 
moderate level of symptoms and none of them are having severe symptoms. Among 
control, 40.0% of the women are having mild level of symptoms, 60.0% of them are 
having moderate level of symptoms and none of them are having severe symptoms. 
Statistically there is a significant difference between experiment and control group. It 
was confirmed using chi square test. (11.91, p=0.0001). 
Thus the level of menopausal symptoms had reduced from moderate tomild level 
through my intervention. 
The Result was supported by Silvina Levis* and Marcio L. Griebeler(2010) where in 
this study,The limitations of these studies include small sample size, short duration, 
the use of different soy foods that contain varying amounts of isoflavones, and 
enrollment of women in a wide age range or who differed in the number and severity 
of menopausal symptoms. Studies evaluating vasomotor symptoms commonly observe 
a significant placebo effect, with up to 30% reduction in hot flashes in the post test 
experimental group; therefore, trials longer than 12 wk are necessary to evaluate the 
sustainability of effects. 
 
 
  
 
Objective3: To evaluate the effectiveness of soya milk on menopausal symptoms 
among postmenopausal women in experimental group. 
On comparison of pretest and posttest mean menopausal symptom score (experiment), 
all the symptoms like hot flushes, sleep disturbances, night sweats, fatigue ,headache, 
irritability, joint discomfort, palpitation are very highly significant when compared 
with vaginal dryness and palpitation. Whereas in control group none of the symptoms 
were significant. 
Finally on comparing, pretest and posttest menopausal symptoms among 
postmenopausal women, in experiment, in pretest women are having 17.17 score and 
in posttest, they are having 10.27 score. Difference is 6.90 score.  The difference 
between pretest and posttest   score is large and it is statistically significant. 
Differences between pretest and posttest score was analyzed using Student paired-test.  
Considering control group in pretest women are having 16.67 score and in posttest, 
they are having 15.50 score. Difference is 1.17 score.  The difference between pretest 
and posttest   score is small and it is not statistically significant. Differences between 
pretest and posttest score was analyzed using Student paired t-test. 
 On comparing pretest and posttest in menopausal symptoms among postmenopausal 
women, in experiment, in pretest women are having 17.17 score and in posttest, they 
are having 10.27 score. Difference is 6.90 score.  The difference between pretest and 
posttest   score is large and it is statistically significant. Differences between pretest 
and posttest score was analyzed using Student paired-test.  
Considering control group in pretest women are having 16.67 score and in posttest, 
they are having 15.50 score. Difference is 1.17 score.  The difference between pretest 
and posttest score is small and it is not statistically significant. Differences between 
pretest and posttest score was analyzed using Student paired t-test. 
 Differences between reassessment and post assessment score was analyze using the 
  
mean difference  and the proportion with 95% confidence interval is 6.90 (p=0.001 
significant) in experimental group and in control group is 1.17(p=0.10 not significant).  
On comparing the symptoms in experimental and control group, the mean difference 
between the experimental and control group in the post test level is 5.23(mean=15.50, 
SD=3, 35).The difference between experiment and control   score is large and it is 
statistically significant. Differences between experiment and control score was 
analyzed using Student independent t-test (t=6.52, p=0.001-significant). This shows 
the effectiveness of soya intervention. 
The above findings consistent with quasi experimental study conducted by 
Maya.c.koshy (2012) to assess the effectiveness of soyabeans on menopausal 
symptoms among 60 post menopausal women in salem district. Data was collected 
using modified Greene climacteric scale. The mean post test menopausal problem 4.37 
was less than the mean pre test 24.93.WKH REWDLQHG ³W´ YDOXH  S ZDV
highly significant. It was concluded that significant reduction in the mean menopausal 
problem after soya bean administration. 
Objective 4: To associate the menopausal symptoms among post menopausal 
women and their selected demographic variables 
On associating the pre test and post test level of post menopausal symptom reduction 
score and demographic variables in experimental group  ,Elder , more educated and 
more income  women  are having more symptoms reduction score  than others. 
Statistical significance was calculated using chi square test( Age x2=8.17, p=0.05, 
education x2=7.49, p=0.05, income x2=7.70, p=0.05) 
In control group, None of the variables are significant. statistical significance was 
calculated using chi square test 
The above findings are considered with the J.josephine (2010) conducted an 
experimental study to evaluate the effectiveness of soya bean on menopausal problems 
in Madurai. The study results that in experimental group, the mean post assessment 
  
status of the selected menopausal problems 13.5 is lower than the mean preassessment 
VWDWXVWKHPHDQGLIIHUHQFHLVDQGWKHREWDLQHG³W´YDOXHLVVLJQLILFDQW
at 0.05 levels. The study concluded that there is a typical reduction in the level of 
menopausal symptoms after administration of soya bean. 
            Through this study more than 75% of postmenopausal women in Choolai were 
benefited. 
Hypotheses :  
H1: There is a significant effect in the reduction of level of physicsl and 
physiological symptoms among the post menopausal women after soya milk with 
honey consumption. 
The net reduction rate of menopausal symptoms among the post menopausal 
ZRPHQZDVSRRRWKHUHLVVWDWLVWLFDOO\VLJQLILFDQWLPSURYHPHQWRQRYHUDOO
domains except for vaginal dryness and palpitation. This proves the effectiveness of 
soya milk with honey consumption on reducing the physical and physiological 
symptoms  on post menopausal women. Hence the hypotheses was proved..  
H2:  
There is a significant association between the reduction level of menopausal 
symptoms among postmenopausal women and their selected demographic variables. 
The assocation of age, education, income with reduction in the physical and 
physiological symptoms is statistLFDOO\ VLJQLILFDQW ZLWK S UHVSHFWLYHO\ 7KXV
certain demographic variables are associated in the reduction level of symptoms. 
Hence hypotheses was accepted 
 
 
 
  
CHAPTER VII 
CONCLUSION AND RECOMMENDATIONS 
The brain of the research project lies in reporting the findings. This is the most 
Creative and demanding part of this study. This chapter gives the brief account 
of Present study, suggestion of the study and nursing implication. This study 
was intended  to analyze the effectiveness of soya milk administration upon 
menopausal symptoms among menopausal women 
 
7.1 Implications: 
  (Tolsma 1995), the findings of the study have the following implications in 
the areas of nursing service, nursing education, nursing administration, and 
research.  
                 Home based treatment to reduce the post menopausal symptoms 
must be taught to combat these symptoms naturally in the community and the 
Community Health Nurse must hold high responsibility in creating awareness 
among the people regarding this complimentary alternative medicines. 
7.1.1 Nursing Service  
It was identified during survey in Choolai village that many women at 
menopausal age were experiencing post menopausal symptoms. Basically it is 
being neglected by the women and not told out. So the community health nurse 
needs to give more importance to the women in menopausal age and the use of 
soya milk as natural remedy to reduce postmenopausal symptoms. In hospital, 
women who underwent hysterectomy (surgical menopause) were not aware of 
menopause, they only consider the surgery. Nurses in the surgical units need to 
educate about menopause to those who underwent hysterectomy while 
discharging the patient. And supportive advice has to be given with regard to 
  
following dietary modification (consuming cabbage, beans, and soya) to reduce 
menopausal symptoms.  
7.1.2 Nursing Education: 
Menopause and its related issues should be a part of curriculum in subjects 
such as, community health nursing. Nursing students should be educated them 
about natural remedies and alternative and complementary therapies for 
menopause as they take care of the women who undergo surgical hysterectomy. 
Nursing education must emphasize primary care approach focusing on 
preventive care. Students can be motivated to conduct mass awareness 
programs on post menopause and its symptoms and management. The 
HPSKDVLVQHHGWREHDSUHYHQWLYHDQGSURPRWLYHKHDOWKSUDFWLFHV7KXVQXUVH¶V
knowledge must be upgraded regarding the clinical focus on periodical 
screening programmes in the community level to promote healthier life for the 
women. 
7.1.3 Nursing administeration: 
1.                             The administrator has the added responsibility in providing 
the continuing education opportunities on the alternative therapy to the nurses 
LQ WRGD\¶V ZRUOG RI DGYDQFHG WHFKQRORJ\ 1XUVH DGPLQLVWUDWRU VKRXOG WDNH
initiative to organize continuing education programs on management of 
menopausal symptoms with supportive treatments like soya milk 
supplementation for the nursing personnel in the hospital and in the community 
setting with modern technological visual aids to enhance knowledge regarding 
non pharmacological ways of reducing menopausal symptoms. A study 
protocol for the implementation of the procedure must be developed. Nurse 
administrators must take interest in formulating the principles and adapting the 
various modalities of treatment for the post menopausal symptoms. Nurses 
must explore their knowledge regarding the health education programmes with 
teaching materials with new innovative ideas. Periodic conference, seminar, 
  
symposium can be arranged for Nursing personnel regarding the care of 
menopausal clients and the new findings regarding their care.  
7.1.4 Nursing research: 
As a result of growing demand, there is a heightened urgency to expand the 
evidence based support in use. It opens the big avenue for research on 
innovative, alternative methods to reduce the menopausal symptoms .Further 
research need to be conducted to help the menopausal women to come out from 
their menopausal symptoms. The professional nurses could conduct further 
studies on the impact of various alternative methods for treating the 
menopausal symptoms as well as to avoid the use of hormone replacement 
therapy and its side effects. The study findings helps to expand the scientific 
body of professional knowledge for further researchers to build up evidence 
based practice.
7.2  Limitation: 
¾ Prolonged effect of soya beans could not be measured. 
¾ The investigator needed much co operation from the menopausal 
women. 
 
7.3  Recommendations: 
The research recommends the following studies in the field of nursing 
research:-  
 The same study could be conducted on larger sample for better generalization. 
 A similar study can be done with other type of soya products. 
 Effectiveness of this soya milk can be compared with other complimentary 
products. 
 A similar study can be done in various settings. 
  
 Effectiveness of soya milk can be compared with the other hormonal 
replacement therapies. 
Conclusion: 
The findings of the study showed that the effectiveness of soya milk 
upon Post menopausal symptoms in experimental group were better than those 
in the control group. Hence it could be concluded that there is an association 
between the post menopausal symptoms and administration of soya milk. Soya 
milk is easy to administer and a natural supplement for menopausal women, 
which can also be prepared at home and consumed.  
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Data Collection Tool 
Section-I 
Demographic variable performa 
Purpose:  
This Performa is used to measure the demographic variable such as age, sex, 
education, occupation, religion, monthly income, number of the year, in areas 
of choolai . 
RESEARCH TOOLS 
INSTRUCTION: 
 Please be frank and free in answering the question.  
 Read each item carefully and answer all the questions. 
 Answers will be used only for research purpose and will be confidential. 
 Please put a tic mark at the appropriate option. 
 
Section-A Demographic Profile 
1. Age 
a. 40-45yrs         [  ] 
b .46-50yrs       [  ] 
c. 51-55yrs       [  ] 
d. 56-60yrs                                                                                  [  ] 
  
2. Religion 
a. Hindu                    [  ] 
b .Muslim       [  ] 
c. Christian       [  ] 
d. Others       [  ] 
3. Educational status 
a. no formal education       [  ] 
b.primary       [  ] 
C. middle school       [  ] 
d.high school and above       [  ] 
4. Occupation 
a. Home maker       [  ] 
b. Govt employment       [  ] 
C. private employment       [  ] 
D. self employment       [  ] 
5. Monthly family income 
a. 3000-5000                 [  ] 
 
  
b. Rs 5000-10000        [  ] 
c. Rs above 10000       [  ] 
d. Below 3000       [  ] 
6. Dietary habits 
a. Vegetarian       [  ] 
b. Non vegetarian       [  ] 
7. Marital status 
a. married       [  ] 
b. unmarried       [  ] 
c .widow       [  ] 
d. divorce       [  ] 
8. How many children do you have? 
a. 1       [  ] 
b. 2       [  ] 
C. > 2       [  ] 
d. 0       [  ] 
9. Do you have any medical illness? 
a. Blood pressure       [  ] 
b.diabetes Mellitus       [  ] 
c. Asthma                [  ] 
 
  
d. other diseases         [  ] 
10. Menopause attained at the age of? 
a. 40-45 yrs        [  ] 
b. 46-50 yrs        [  ] 
c. 51-55yrs        [  ] 
d. 60 above        [  ] 
11. Whether or taken treatment for menopause? 
a.   yes        [  ] 
b. No        [  ] 
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Soya milk preparation : 
The soya bean (Glycine max) belongs to the legume family. Legumes features 
phyto nutrients that lend some unique benefits to women in their 
menopauasal and post menopausal stages. These soy products are highly rich 
in isoflavones , the most widely studied class of phyto nutrients.the message 
that soy phytoestrogens act, in effect, as surrogate estrogens. Each gram of 
soya protein in soya beans and traditional soya foods provides approximately 
3.5mg of isoflavones. 
PURPOSES: 
 SOY products are good source of protein and has been consumed by asian 
populations. 
  The effects of soy isoflavones observed on physical and physiological 
ƐǇŵƉƚŽŵƐŚĞůƉƐƚŽƌĚƵĐĞŚŽƚĨůĂƐŚĞƐ͕ŶŝŐŚƚƐǁĞĂƚƐĞƚĐ͙ 
 soy phytoestrogens do have the estrogenic effect of stimulating the growth of 
breast cancer cells in tissue cultures. 
 50 gms of soya contains; 
9 Phytooestrogens-20mg 
9 Energy-223k.cal. 
9 Carbohydrates-10.45gm 
9 Dietary fibre-5gm 
9 Fat-9.75gm 
9 Proteins-21.6gm 
9 Vitamin A-1moq,vitamin B-0.133mg,vitamin C-3mg 
9 Vitamin K-2.7mg , Calcium-120mg, magnesium-140mg. 
Procedure: 
Soak 50 gm of soya bean in water the previous night. The next day morning 
pour 100ml of water and blend thoroughly using mixie.The extract of 100ml of 
soya milk should be taken by filtering it in a cheese cloth.The obtained extract 
must be boiled for a while(10min) .After it is cooled, about a teaspoon-5ml of 
honey should bw added for flavor and must be administered. 
 
  
 
INFORMATION TO PARTICIPANTS 
Title of the study :   
  A study to assess the effectiveness of soya milk consumption on 
reducing physical and physiological symptoms among the postmenopausal 
women in the age group 40-60 yrs in selected urban community at choolai 
 
Name of the Participant : 
Date    : 
Age/sex   :      
Investigator              : V. Sangeetha 
Name of the institution : urban community area, choolai 
Enrollment No  : 
You are invited to take part in this study. The information in this 
document is meant to help you decide whether or not to take part. Please feel 
free to ask if you have any queries or concerns. 
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